Altered	B-protein
DNA-binding	I-protein
specificity	I-protein
mutants	I-protein
of	O
EKLF	B-protein
and	O
Sp1	O
show	O
that	O
EKLF	B-protein
is	O
an	O
activator	O
of	O
the	O
beta-globin	B-DNA
locus	I-DNA
control	I-DNA
region	I-DNA
in	O
vivo	O
.	O

The	O
locus	B-DNA
control	I-DNA
region	I-DNA
of	O
the	O
beta-globin	B-DNA
cluster	I-DNA
contains	O
five	O
DNase	B-DNA
I	I-DNA
hypersensitive	I-DNA
sites	I-DNA
(	O
5'HS1-5	B-DNA
)	O
required	O
for	O
locus	O
activation	O
.	O

5'HS3	B-DNA
contains	O
six	O
G-rich	O
motifs	O
that	O
are	O
essential	O
for	O
its	O
activity	O
.	O

Members	O
of	O
a	O
protein	O
family	O
,	O
characterized	O
by	O
three	O
zinc	B-protein
fingers	I-protein
highly	O
homologous	O
to	O
those	O
found	O
in	O
transcription	B-protein
factor	I-protein
Sp1	I-protein
,	O
interact	O
with	O
these	O
motifs	O
.	O

Because	O
point	O
mutagenesis	O
can	O
not	O
distinguish	O
between	O
family	O
members	O
,	O
it	O
is	O
not	O
known	O
which	O
protein	O
activates	O
5'HS3	B-DNA
.	O

We	O
show	O
that	O
the	O
function	O
of	O
such	O
closely	O
related	O
proteins	O
can	O
be	O
distinguished	O
in	O
vivo	O
by	O
matching	O
point	O
mutations	O
in	O
5'HS3	B-DNA
with	O
amino	O
acid	O
changes	O
in	O
the	O
zinc	B-protein
fingers	I-protein
of	O
Sp1	B-protein
and	O
EKLF	B-protein
.	O

Testing	O
their	O
activity	O
in	O
transgenic	O
mice	O
shows	O
that	O
EKLF	B-protein
is	O
a	O
direct	O
activator	O
of	O
5'HS3	B-DNA
.	O

Altered	NULL
DNA-binding	NULL
specificity	NULL
mutants	NULL
of	NULL
EKLF	NULL
and	NULL
Spl	NULL
show	NULL
that	NULL
EKLF	NULL
is	NULL
an	NULL
activator	NULL
of	NULL
the	NULL
B-globin	NULL
locus	NULL
control	NULL
region	NULL
in	NULL
vivo	NULL
Nynke	NULL
Gillemans	NULL
,	NULL
Rita	NULL
Tewari	NULL
,	NULL
Fokke	NULL
Lindeboom	NULL
,	NULL
Robbert	NULL
Rottier	NULL
,	NULL
Ton	NULL
de	NULL
Wit	NULL
,	NULL
Mark	NULL
Wijgerde	NULL
,	NULL
Frank	NULL
Grosveld	NULL
,	NULL
``	NULL
and	NULL
Sjaak	NULL
Philipsen	NULL
Erasmus	NULL
University	NULL
Rotterdam	NULL
,	NULL
Medical	NULL
Genetics	NULL
Center-Department	NULL
of	NULL
Cell	NULL
Biology	NULL
,	NULL
3000	NULL
DR	NULL
Rotterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
The	NULL
locus	NULL
control	NULL
region	NULL
of	NULL
the	NULL
B-globin	NULL
cluster	NULL
contains	NULL
five	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
(	NULL
5'HS1-5	NULL
)	NULL
required	NULL
for	NULL
locus	NULL
activation	NULL
.	NULL

5	NULL
!	NULL

HS3	NULL
contains	NULL
six	NULL
G-rich	NULL
motifs	NULL
that	NULL
are	NULL
essential	NULL
for	NULL
its	NULL
activity	NULL
.	NULL

Members	NULL
of	NULL
a	NULL
protein	NULL
family	NULL
,	NULL
characterized	NULL
by	NULL
three	NULL
zinc	NULL
fingers	NULL
highly	NULL
homologous	NULL
to	NULL
those	NULL
found	NULL
in	NULL
transcription	NULL
factor	NULL
Sp1	NULL
,	NULL
interact	NULL
with	NULL
these	NULL
motifs	NULL
.	NULL

Because	NULL
point	NULL
mutagenesis	NULL
can	NULL
not	NULL
distinguish	NULL
between	NULL
family	NULL
members	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
which	NULL
protein	NULL
activates	NULL
5'HS3	NULL
.	NULL

We	NULL
show	NULL
that	NULL
the	NULL
function	NULL
of	NULL
such	NULL
closely	NULL
related	NULL
proteins	NULL
can	NULL
be	NULL
distinguished	NULL
in	NULL
vivo	NULL
by	NULL
matching	NULL
point	NULL
mutations	NULL
in	NULL
5'HS3	NULL
with	NULL
amino	NULL
acid	NULL
changes	NULL
in	NULL
the	NULL
zinc	NULL
fingers	NULL
of	NULL
Sp1	NULL
and	NULL
EKLF	NULL
.	NULL

Testing	NULL
their	NULL
activity	NULL
in	NULL
transgenic	NULL
mice	NULL
shows	NULL
that	NULL
EKLF	NULL
is	NULL
a	NULL
direct	NULL
activator	NULL
of	NULL
5HS3	NULL
.	NULL

[	NULL
Key	NULL
Words	NULL
:	NULL
Zinc	NULL
fingers	NULL
;	NULL
binding	NULL
site	NULL
specificity	NULL
;	NULL
locus	NULL
control	NULL
region	NULL
;	NULL
Spl	NULL
;	NULL
EKLF	NULL
;	NULL
transcriptional	NULL
activation	NULL
;	NULL
globin	NULL
]	NULL
Received	NULL
June	NULL
5	NULL
,	NULL
1998	NULL
;	NULL
revised	NULL
version	NULL
accepted	NULL
July	NULL
29	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
human	NULL
B-globin	NULL
cluster	NULL
contains	NULL
five	NULL
structural	NULL
genes	NULL
in	NULL
the	NULL
order	NULL
5'-e	NULL
(	NULL
embryonic	NULL
)	NULL
-Gy-Ay	NULL
(	NULL
fetal	NULL
)	NULL
-6-B	NULL
(	NULL
adult	NULL
)	NULL
-3	NULL
'	NULL
.	NULL

Expression	NULL
of	NULL
these	NULL
genes	NULL
is	NULL
completely	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
locus	NULL
control	NULL
region	NULL
(	NULL
LCR	NULL
)	NULL
,	NULL
a	NULL
20-kb	NULL
sequence	NULL
located	NULL
upstream	NULL
of	NULL
the	NULL
e-globin	NULL
gene	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Grosveld	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

The	NULL
LCR	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
five	NULL
erythroid-specific	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
,	NULL
termed	NULL
5'HS1-5	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
LCR	NULL
resides	NULL
in	NULL
the	NULL
hypersensitive	NULL
areas	NULL
(	NULL
Grosveld	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Our	NULL
previous	NULL
work	NULL
has	NULL
focused	NULL
on	NULL
the	NULL
functional	NULL
dissection	NULL
of	NULL
5HS3	NULL
of	NULL
the	NULL
LCR	NULL
.	NULL

It	NULL
is	NULL
the	NULL
strongest	NULL
activator	NULL
when	NULL
single	NULL
hypersensitive	NULL
sites	NULL
are	NULL
linked	NULL
to	NULL
the	NULL
B-globin	NULL
gene	NULL
(	NULL
Fraser	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
)	NULL
,	NULL
and	NULL
it	NULL
appears	NULL
to	NULL
have	NULL
a	NULL
dominant	NULL
chromatin-opening	NULL
activity	NULL
(	NULL
Ellis	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

The	NULL
225-bp	NULL
core	NULL
fragment	NULL
coinciding	NULL
with	NULL
the	NULL
hypersensitive	NULL
site	NULL
retains	NULL
the	NULL
essential	NULL
properties	NULL
of	NULL
5'HS3	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
)	NULL
.	NULL

This	NULL
core	NULL
contains	NULL
three	NULL
footprinted	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
erythroid-specific	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
,	NULL
alternated	NULL
with	NULL
three	NULL
footprinted	NULL
G-rich	NULL
sequences	NULL
or	NULL
G	NULL
boxes	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
;	NULL
Strauss	NULL
and	NULL
Orkin	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
smallest	NULL
fragment	NULL
capable	NULL
of	NULL
activating	NULL
a	NULL
B-globin	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
consists	NULL
of	NULL
footprints	NULL
1-3	NULL
(	NULL
fp	NULL
1-3	NULL
)	NULL
of	NULL
the	NULL
core	NULL
fragment	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Fp	NULL
1	NULL
and	NULL
3	NULL
are	NULL
GATA-1	NULL
binding	NULL
sites	NULL
,	NULL
and	NULL
fp	NULL
2	NULL
contains	NULL
G	NULL
boxes	NULL
that	NULL
are	NULL
bound	NULL
by	NULL
multiple	NULL
factors	NULL
.	NULL

*Corresponding	NULL
author	NULL
.	NULL

E-MAIL	NULL
vangeest	NULL
@	NULL
ch1.fgg.cur.nl	NULL
;	NULL
FAX	NULL
31-10-436	NULL
0225	NULL
.	NULL

Point	NULL
mutations	NULL
in	NULL
fp	NULL
1	NULL
and	NULL
3	NULL
have	NULL
shown	NULL
that	NULL
intactness	NULL
of	NULL
these	NULL
sequences	NULL
is	NULL
absolutely	NULL
essential	NULL
for	NULL
activity	NULL
.	NULL

From	NULL
this	NULL
,	NULL
we	NULL
concluded	NULL
that	NULL
GATA-1	NULL
binds	NULL
to	NULL
fp	NULL
1	NULL
and	NULL
3	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
point	NULL
mutations	NULL
abolishing	NULL
binding	NULL
of	NULL
single	NULL
factors	NULL
to	NULL
the	NULL
G	NULL
boxes	NULL
of	NULL
fp	NULL
2	NULL
could	NULL
not	NULL
be	NULL
designed	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

The	NULL
G	NULL
boxes	NULL
are	NULL
bound	NULL
by	NULL
members	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
family	NULL
characterized	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
three	NULL
zinc	NULL
fingers	NULL
highly	NULL
hom	NULL
olo-gous	NULL
to	NULL
those	NULL
found	NULL
in	NULL
Spl	NULL
.	NULL

The	NULL
Spl	NULL
family	NULL
includes	NULL
ubiquitously	NULL
expressed	NULL
proteins	NULL
like	NULL
Spl	NULL
(	NULL
Kadonaga	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
,	NULL
Sp3	NULL
(	NULL
Hagen	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
;	NULL
Kingsley	NULL
and	NULL
Winoto	NULL
1992	NULL
)	NULL
,	NULL
basic	NULL
transcription	NULL
element	NULL
binding	NULL
protein	NULL
(	NULL
BTEBs	NULL
;	NULL
Imataka	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
)	NULL
and	NULL
basic	NULL
Kriippel-like	NULL
factor	NULL
(	NULL
BKLF	NULL
;	NULL
Crossley	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
,	NULL
and	NULL
tissue-restricted	NULL
factors	NULL
like	NULL
gut-enriched	NULL
Kriippel-like	NULL
factor	NULL
(	NULL
GKLF	NULL
;	NULL
Shields	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
,	NULL
lung	NULL
Kriippel-like	NULL
factor	NULL
(	NULL
LKLF	NULL
;	NULL
Anderson	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
)	NULL
,	NULL
and	NULL
erythroid	NULL
Kriippel-like	NULL
factor	NULL
(	NULL
EKLF	NULL
;	NULL
Miller	NULL
and	NULL
Bieker	NULL
1993	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
large	NULL
num	NULL
ber	NULL
of	NULL
Spl-like	NULL
zinc	NULL
finger	NULL
domains	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
expressed	NULL
sequence	NULL
tag	NULL
(	NULL
EST	NULL
)	NULL
databases	NULL
.	NULL

Fp	NULL
2	NULL
is	NULL
bound	NULL
in	NULL
vitro	NULL
by	NULL
Sp1	NULL
,	NULL
Sp3	NULL
,	NULL
BKLF	NULL
,	NULL
EKLF	NULL
,	NULL
and	NULL
other	NULL
as	NULL
yet	NULL
uncharacterized	NULL
family	NULL
members	NULL
,	NULL
present	NULL
in	NULL
erythroid	NULL
nuclear	NULL
extracts	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
N.	NULL
Gillemans	NULL
,	NULL
unpubl	NULL
.	NULL
)	NULL

.	NULL

This	NULL
plethora	NULL
of	NULL
transcription	NULL
factors	NULL
precludes	NULL
a	NULL
straightforward	NULL
interpretation	NULL
of	NULL
the	NULL
relationship	NULL
between	NULL
binding	NULL
sites	NULL
and	NULL
activators	NULL
,	NULL
and	NULL
thus	NULL
it	NULL
is	NULL
not	NULL
known	NULL
which	NULL
protein	NULL
binds	NULL
to	NULL
fp	NULL
2	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
apparent	NULL
redundancy	NULL
of	NULL
transcription	NULL
factors	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
12:2863-2873	NULL
©	NULL
1998	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
ISSN	NULL
0890-9369/98	NULL
$	NULL
5.00	NULL
;	NULL
www.genesdev.org	NULL
2863	NULL
Gillemans	NULL
et	NULL
al	NULL
.	NULL

presents	NULL
a	NULL
general	NULL
problem	NULL
in	NULL
the	NULL
interpretation	NULL
of	NULL
gene	NULL
expression	NULL
data	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
knockout	NULL
mice	NULL
is	NULL
a	NULL
first	NULL
step	NULL
toward	NULL
the	NULL
solution	NULL
of	NULL
this	NULL
problem	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
Nuez	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
;	NULL
Perkins	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
;	NULL
Marin	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
;	NULL
Tewari	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
)	NULL
,	NULL
but	NULL
this	NULL
approach	NULL
can	NULL
only	NULL
provide	NULL
indirect	NULL
an-swers	NULL
.	NULL

Pioneering	NULL
work	NULL
in	NULL
Drosophila	NULL
has	NULL
established	NULL
that	NULL
a	NULL
DNA-binding	NULL
specificity	NULL
mutant	NULL
can	NULL
be	NULL
used	NULL
as	NULL
a	NULL
tool	NULL
to	NULL
demonstrate	NULL
direct	NULL
interaction	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
and	NULL
a	NULL
DN	NULL
A	NULL
target	NULL
site	NULL
in	NULL
a	NULL
multicellular	NULL
organism	NULL
(	NULL
Schier	NULL
and	NULL
Gehring	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
we	NULL
have	NULL
applied	NULL
this	NULL
approach	NULL
to	NULL
mice	NULL
,	NULL
utilizing	NULL
the	NULL
minimal	NULL
fragment	NULL
of	NULL
5'HS3	NULL
to	NULL
test	NULL
the	NULL
role	NULL
of	NULL
putative	NULL
activator	NULL
proteins	NULL
(	NULL
Spl	NULL
and	NULL
EKLF	NULL
)	NULL
directly	NULL
.	NULL

First	NULL
,	NULL
we	NULL
mutated	NULL
the	NULL
G	NULL
boxes	NULL
in	NULL
fp	NULL
2	NULL
so	NULL
they	NULL
no	NULL
longer	NULL
bind	NULL
Spl	NULL
family	NULL
members	NULL
in	NULL
vitro	NULL
.	NULL

Second	NULL
,	NULL
we	NULL
designed	NULL
zinc	NULL
fingers	NULL
recognizing	NULL
the	NULL
mutated	NULL
sequence	NULL
in	NULL
fp	NULL
2	NULL
.	NULL

We	NULL
then	NULL
tested	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
engineered	NULL
factors	NULL
(	NULL
mSpl	NULL
and	NULL
mEKLF	NULL
)	NULL
to	NULL
activate	NULL
the	NULL
mutant	NULL
fp	NULL
2	NULL
construct	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
EKLF	NULL
but	NULL
not	NULL
Spl	NULL
activates	NULL
fp	NULL
2	NULL
of	NULL
5'HS3	NULL
,	NULL
and	NULL
we	NULL
conclude	NULL
that	NULL
EKLF	NULL
plays	NULL
a	NULL
very	NULL
specific	NULL
role	NULL
in	NULL
the	NULL
activity	NULL
of	NULL
5'HS3	NULL
and	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
B-globin	NULL
locus	NULL
.	NULL

Results	NULL
Experim	NULL
ental	NULL
strategy	NULL
We	NULL
have	NULL
used	NULL
human	NULL
B-globin	NULL
gene	NULL
activation	NULL
by	NULL
the	NULL
minimal	NULL
fragment	NULL
of	NULL
5'HS3	NULL
as	NULL
the	NULL
experimental	NULL
system	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
functional	NULL
importance	NULL
of	NULL
the	NULL
GAT	NULL
sites	NULL
in	NULL
fp	NULL
1	NULL
and	NULL
3	NULL
and	NULL
the	NULL
G	NULL
boxes	NULL
in	NULL
fp	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
has	NULL
been	NULL
analyzed	NULL
extensively	NULL
in	NULL
transgenic	NULL
mice	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
show	NULL
that	NULL
all	NULL
three	NULL
footprinted	NULL
sequences	NULL
are	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
a	NULL
linked	NULL
B-globin	NULL
gene	NULL
.	NULL

Spl	NULL
family	NULL
members	NULL
recognize	NULL
a	NULL
9-bp	NULL
sequence	NULL
GGG	NULL
GT/CG	NULL
GGG	NULL
(	NULL
Letovsky	NULL
and	NULL
Dynan	NULL
1989	NULL
)	NULL
and	NULL
thus	NULL
it	NULL
could	NULL
be	NULL
predicted	NULL
that	NULL
fp	NULL
2	NULL
contains	NULL
two	NULL
overlapping	NULL
binding	NULL
sites	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
potential	NULL
weaker	NULL
binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
wild	NULL
type	NULL
)	NULL
.	NULL

To	NULL
minimize	NULL
the	NULL
complexity	NULL
of	NULL
fp	NULL
2	NULL
,	NULL
we	NULL
first	NULL
determined	NULL
whether	NULL
one	NULL
binding	NULL
site	NULL
would	NULL
suffice	NULL
for	NULL
activation	NULL
.	NULL

Two	NULL
mutants	NULL
with	NULL
only	NULL
one	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
5	NULL
'	NULL
and	NULL
3	NULL
``	NULL
)	NULL
were	NULL
made	NULL
by	NULL
disrupting	NULL
every	NULL
other	NULL
potential	NULL
binding	NULL
site	NULL
by	NULL
G	NULL
-T	NULL
transversions	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

These	NULL
mutants	NULL
were	NULL
placed	NULL
in	NULL
their	NULL
natural	NULL
context	NULL
between	NULL
fp	NULL
1	NULL
and	NULL
3	NULL
and	NULL
the	NULL
resulting	NULL
fragments	NULL
were	NULL
tested	NULL
for	NULL
their	NULL
capacity	NULL
to	NULL
activate	NULL
the	NULL
B-globin	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Founder	NULL
fetuses	NULL
were	NULL
dissected	NULL
at	NULL
13.5	NULL
days	NULL
of	NULL
gestation	NULL
(	NULL
E13.5	NULL
)	NULL
,	NULL
and	NULL
DNA	NULL
was	NULL
prepared	NULL
from	NULL
the	NULL
head	NULL
,	NULL
yolk	NULL
sac	NULL
,	NULL
and	NULL
placenta	NULL
to	NULL
determine	NULL
the	NULL
transgene	NULL
copy	NULL
number	NULL
and	NULL
to	NULL
check	NULL
for	NULL
mosaicism	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

RN	NULL
A	NULL
was	NULL
isolated	NULL
from	NULL
the	NULL
livers	NULL
of	NULL
nonmosaic	NULL
transgenic	NULL
fe-tuses	NULL
,	NULL
and	NULL
the	NULL
level	NULL
of	NULL
human	NULL
B-globin	NULL
mRNA	NULL
was	NULL
quantitated	NULL
with	NULL
S1	NULL
nuclease	NULL
protection	NULL
analysis	NULL
using	NULL
the	NULL
level	NULL
of	NULL
the	NULL
endogenous	NULL
B-major	NULL
mRNA	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
level	NULL
per	NULL
transgene	NULL
copy	NULL
was	NULL
set	NULL
at	NULL
100	NULL
for	NULL
the	NULL
wild-type	NULL
fp	NULL
1-3	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
constructs	NULL
with	NULL
only	NULL
one	NULL
G	NULL
box	NULL
in	NULL
fp	NULL
2	NULL
are	NULL
expressed	NULL
at	NULL
approximately	NULL
twofold	NULL
lower	NULL
levels	NULL
than	NULL
those	NULL
observed	NULL
with	NULL
the	NULL
wild-type	NULL
fp	NULL
1-3	NULL
con	NULL
2864	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
70	NULL
80	NULL
kb	NULL
1	NULL
ko	NULL
Exp	NULL
.	NULL

:	NULL
(	NULL
100	NULL
+20	NULL
6	NULL
47	NULL
£17	NULL
8	NULL
3	NULL
(	NULL
cf	NULL
}	NULL
TCCASTGAGIT	NULL
seTcesemicactccrmest	NULL
SBI	NULL
5	NULL
F3	NULL
0	NULL
F2	NULL
FI	NULL
mulan	NULL
(	NULL
mt	NULL
)	NULL
11	NULL
%	NULL
7	NULL
8	NULL
Figure	NULL
1	NULL
.	NULL

Activity	NULL
of	NULL
the	NULL
fp	NULL
1-3	NULL
fragment	NULL
5'HS3	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
LCR	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
drawing	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
locus	NULL
.	NULL

The	NULL
hypersensitive	NULL
sites	NULL
of	NULL
the	NULL
LCR	NULL
are	NULL
indicated	NULL
by	NULL
downward	NULL
arrows	NULL
,	NULL
the	NULL
genes	NULL
by	NULL
solid	NULL
boxes	NULL
(	NULL
fop	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
fp	NULL
1-3	NULL
of	NULL
5HS3	NULL
was	NULL
analyzed	NULL
in	NULL
transgenic	NULL
mice	NULL
using	NULL
the	NULL
Hpal-EcoRV	NULL
fragment	NULL
of	NULL
the	NULL
B-globin	NULL
gene	NULL
as	NULL
the	NULL
reporter	NULL
gene	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Quantitation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
fp	NULL
1-3	NULL
constructs	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
fp	NULL
1-3	NULL
area	NULL
is	NULL
shown	NULL
(	NULL
fop	NULL
)	NULL
.	NULL

Strong	NULL
GATA-1	NULL
binding	NULL
sites	NULL
are	NULL
underlined	NULL
with	NULL
thin	NULL
arrows	NULL
;	NULL
weak	NULL
GATA-1	NULL
binding	NULL
sites	NULL
with	NULL
broken	NULL
arrows	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
,	NULL
the	NULL
two	NULL
G-rich	NULL
motifs	NULL
in	NULL
fp	NULL
2	NULL
are	NULL
underlined	NULL
with	NULL
bold	NULL
arrows	NULL
.	NULL

Permutations	NULL
of	NULL
fp	NULL
2	NULL
analyzed	NULL
in	NULL
transgenic	NULL
founder	NULL
fetuses	NULL
are	NULL
shown	NULL
below	NULL
.	NULL

The	NULL
G-rich	NULL
motifs	NULL
are	NULL
boxed	NULL
.	NULL

Point	NULL
mutations	NULL
introduced	NULL
are	NULL
in	NULL
boldface	NULL
and	NULL
un-derlined	NULL
.	NULL

A	NULL
shaded	NULL
box	NULL
highlights	NULL
the	NULL
mutant	NULL
binding	NULL
site	NULL
.	NULL

Nucleotides	NULL
interacting	NULL
with	NULL
the	NULL
zinc	NULL
fingers	NULL
of	NULL
Spl	NULL
family	NULL
members	NULL
are	NULL
underscored	NULL
with	NULL
solid	NULL
lines	NULL
(	NULL
F1	NULL
,	NULL
F2	NULL
,	NULL
F3	NULL
)	NULL
,	NULL
as	NULL
are	NULL
nucleotides	NULL
in	NULL
the	NULL
mutant	NULL
binding	NULL
site	NULL
interacting	NULL
with	NULL
the	NULL
mutant	NULL
zinc	NULL
fingers	NULL
(	NULL
mF1	NULL
,	NULL
mF3	NULL
)	NULL
.	NULL

Expression	NULL
levels	NULL
(	NULL
Expr	NULL
.	NULL
)	NULL

are	NULL
given	NULL
with	NULL
standard	NULL
deviations	NULL
,	NULL
and	NULL
the	NULL
num	NULL
ber	NULL
of	NULL
independent	NULL
transgenics	NULL
analyzed	NULL
is	NULL
indicated	NULL
(	NULL
r	NULL
)	NULL
.	NULL

struct	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
each	NULL
G	NULL
box	NULL
contributes	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
fp	NULL
1-3	NULL
.	NULL

Because	NULL
the	NULL
3	NULL
'	NULL
sequence	NULL
has	NULL
the	NULL
best	NULL
match	NULL
with	NULL
the	NULL
Spl	NULL
consensus	NULL
binding	NULL
site	NULL
(	NULL
Letovsky	NULL
and	NULL
Dynan	NULL
1989	NULL
)	NULL
,	NULL
we	NULL
concentrated	NULL
on	NULL
this	NULL
mo-tif	NULL
.	NULL

For	NULL
reasons	NULL
of	NULL
clarity	NULL
,	NULL
we	NULL
will	NULL
refer	NULL
to	NULL
this	NULL
perm	NULL
uta-tion	NULL
of	NULL
fp	NULL
2	NULL
as	NULL
control	NULL
(	NULL
ct	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
hereafter	NULL
.	NULL

The	NULL
zinc	NULL
fingers	NULL
of	NULL
Spl	NULL
family	NULL
members	NULL
are	NULL
structurally	NULL
closely	NULL
related	NULL
to	NULL
those	NULL
of	NULL
the	NULL
Zif268	NULL
protein	NULL
(	NULL
Na-rayan	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
;	NULL
Sjottem	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

From	NULL
the	NULL
crystal	NULL
structure	NULL
of	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
Zif268	NULL
it	NULL
is	NULL
known	NULL
that	NULL
one	NULL
zinc	NULL
finger	NULL
occupies	NULL
3	NULL
bp	NULL
in	NULL
the	NULL
recognition	NULL
sequence	NULL
(	NULL
Pavletich	NULL
and	NULL
Pabo	NULL
1991	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
assumed	NULL
that	NULL
fingers	NULL
1	NULL
and	NULL
3	NULL
recognize	NULL
the	NULL
triplet	NULL
GGG	NULL
,	NULL
and	NULL
finger	NULL
2	NULL
the	NULL
triplet	NULL
GTG	NULL
in	NULL
fp	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
mutation	NULL
of	NULL
GGG	NULL
to	NULL
GTG	NULL
triplets	NULL
should	NULL
interfere	NULL
with	NULL
recognition	NULL
by	NULL
fingers	NULL
1	NULL
and	NULL
3	NULL
of	NULL
Spl	NULL
family	NULL
members	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
fp	NULL
2	NULL
mutant	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
eight	NULL
founder	NULL
fetuses	NULL
shows	NULL
that	NULL
the	NULL
fp	NULL
2	NULL
mutant	NULL
results	NULL
in	NULL
a	NULL
further	NULL
fourfold	NULL
reduction	NULL
of	NULL
B-globin	NULL
reporter	NULL
expression	NULL
as	NULL
compared	NULL
with	NULL
control	NULL
fp	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
earlier	NULL
observations	NULL
in	NULL
transgenic	NULL
mice	NULL
containing	NULL
more	NULL
drastic	NULL
mutations	NULL
in	NULL
fp	NULL
2	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
lower	NULL
expression	NULL
level	NULL
is	NULL
due	NULL
to	NULL
decreased	NULL
binding	NULL
of	NULL
an	NULL
activator	NULL
protein	NULL
to	NULL
the	NULL
mutant	NULL
fp	NULL
2	NULL
sequence	NULL
and	NULL
that	NULL
the	NULL
fp	NULL
2	NULL
mutant	NULL
could	NULL
be	NULL
used	NULL
to	NULL
test	NULL
the	NULL
transcriptional	NULL
effect	NULL
of	NULL
modified	NULL
activator	NULL
proteins	NULL
engineered	NULL
to	NULL
bind	NULL
specifically	NULL
to	NULL
this	NULL
sequence	NULL
.	NULL

Construction	NULL
of	NULL
transcription	NULL
factors	NULL
with	NULL
altered	NULL
DNA-binding	NULL
site	NULL
specificity	NULL
We	NULL
set	NULL
out	NULL
to	NULL
change	NULL
the	NULL
DNA-binding	NULL
site	NULL
specificity	NULL
of	NULL
two	NULL
candidate	NULL
activators	NULL
of	NULL
5'HS3	NULL
:	NULL
Sp1	NULL
,	NULL
the	NULL
ubiquitously	NULL
expressed	NULL
archetypal	NULL
transcription	NULL
factor	NULL
,	NULL
and	NULL
EKLF	NULL
,	NULL
the	NULL
only	NULL
erythroid-specific	NULL
Spl	NULL
family	NULL
member	NULL
described	NULL
to	NULL
date	NULL
.	NULL

The	NULL
fp	NULL
2	NULL
mutant	NULL
contains	NULL
a	NULL
9-bp	NULL
sequence	NULL
consisting	NULL
of	NULL
three	NULL
GTG	NULL
triplets	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
wild-type	NULL
Spl	NULL
family	NULL
mem	NULL
bers	NULL
,	NULL
zinc	NULL
finger	NULL
2	NULL
recognizes	NULL
this	NULL
sequence	NULL
(	NULL
Li	NULL
et	NULL
al	NULL
.	NULL

1991	NULL
;	NULL
Feng	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
;	NULL
Narayan	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
;	NULL
Sjottem	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
if	NULL
we	NULL
would	NULL
change	NULL
the	NULL
specificity	NULL
of	NULL
fingers	NULL
1	NULL
and	NULL
3	NULL
of	NULL
EKLF	NULL
and	NULL
Spl	NULL
to	NULL
that	NULL
of	NULL
finger	NULL
2	NULL
,	NULL
we	NULL
EKLF	NULL
but	NULL
not	NULL
Sp1	NULL
is	NULL
an	NULL
activator	NULL
of	NULL
the	NULL
LCR	NULL
should	NULL
obtain	NULL
proteins	NULL
that	NULL
interact	NULL
specifically	NULL
with	NULL
the	NULL
fp	NULL
2	NULL
mutant	NULL
.	NULL

However	NULL
,	NULL
such	NULL
changes	NULL
may	NULL
have	NULL
unexpected	NULL
consequences	NULL
.	NULL

A	NULL
simple	NULL
triplication	NULL
of	NULL
finger	NULL
2	NULL
of	NULL
Spl	NULL
binds	NULL
to	NULL
such	NULL
a	NULL
sequence	NULL
albeit	NULL
with	NULL
reduced	NULL
affinity	NULL
(	NULL
Desjarlais	NULL
and	NULL
Berg	NULL
1993	NULL
)	NULL
,	NULL
which	NULL
might	NULL
be	NULL
due	NULL
to	NULL
structural	NULL
determinants	NULL
provided	NULL
by	NULL
fingers	NULL
1	NULL
and	NULL
3	NULL
,	NULL
and/or	NULL
the	NULL
spacer	NULL
amino	NULL
acids	NULL
between	NULL
the	NULL
fingers	NULL
(	NULL
Jacobs	NULL
1992	NULL
;	NULL
Choo	NULL
and	NULL
Klug	NULL
1993	NULL
;	NULL
Isalan	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
zinc	NULL
fingers	NULL
are	NULL
involved	NULL
in	NULL
protein-protein	NULL
interactions	NULL
(	NULL
Perkins	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
;	NULL
Merika	NULL
and	NULL
Orkin	NULL
1995	NULL
)	NULL
and	NULL
notably	NULL
,	NULL
the	NULL
interactions	NULL
with	NULL
GATA-1	NULL
are	NULL
of	NULL
direct	NULL
relevance	NULL
to	NULL
this	NULL
work	NULL
(	NULL
Merika	NULL
and	NULL
Orkin	NULL
1995	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
substituted	NULL
the	NULL
minimum	NULL
number	NULL
of	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
recognition	NULL
helices	NULL
of	NULL
fingers	NULL
1	NULL
and	NULL
3	NULL
to	NULL
make	NULL
their	NULL
DNA-binding	NULL
specificity	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
finger	NULL
2	NULL
of	NULL
Spl	NULL
(	NULL
Pavletich	NULL
and	NULL
Pabo	NULL
1991	NULL
;	NULL
Narayan	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
;	NULL
Sjottem	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

No	NULL
other	NULL
changes	NULL
to	NULL
the	NULL
zinc	NULL
finger	NULL
domains	NULL
of	NULL
Spl	NULL
and	NULL
EKLF	NULL
were	NULL
made	NULL
to	NULL
preserve	NULL
presumptive	NULL
functions	NULL
other	NULL
than	NULL
direct	NULL
DNA	NULL
recognition	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
;	NULL
m	NULL
Spl	NULL
and	NULL
m	NULL
EKLF	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
transcription	NULL
factors	NULL
are	NULL
transcriptional	NULL
activators	NULL
First	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
m	NULL
EKLF	NULL
and	NULL
mSp1	NULL
would	NULL
be	NULL
active	NULL
as	NULL
transcriptional	NULL
activators	NULL
in	NULL
a	NULL
binding	NULL
site	NULL
A	NULL
Finger	NULL
1	NULL
Finger	NULL
2	NULL
Finger	NULL
3	NULL
Figure	NULL
2	NULL
.	NULL

Spl	NULL
family	NULL
members	NULL
with	NULL
novel	NULL
Spi	NULL
Hice	NULL
nus	NULL
-	NULL
Dinding	NULL
site	NULL
specificity	NULL
.	NULL

(	NULL
4	NULL
)	NULL
The	NULL
amino	NULL
acid	NULL
mSp	NULL
?	NULL

``	NULL
**	NULL
***	NULL
seres	NULL
20200000	NULL
1000000000	NULL
FJEJF	NULL
'	NULL
Lolli	NULL
le	NULL
ction	NULL
t.	NULL
?	NULL

psoeroe	NULL
1002	NULL
sequence	NULL
of	NULL
the	NULL
three	NULL
zinc	NULL
fingers	NULL
of	NULL
Spl	NULL
is	NULL
|	NULL
|	NULL
shown	NULL
(	NULL
fop	NULL
)	NULL
.	NULL

B-Sheets	NULL
are	NULL
shown	NULL
as	NULL
zigzag	NULL
EKLE	NULL
|	NULL
-T-mae	NULL
.	NULL

-	NULL
-	NULL
-T-	NULL
~-	NULL
-K-	NULL
Y4-8-DG-DME	NULL
-	NULL
A	NULL
@	NULL
SDELTR	NULL
-¥	NULL
-K	NULL
--	NULL
-HAP-C-GL-	NULL
-RA-SRSOHLALOM-R-L	NULL
0	NULL
and	NULL
a-helices	NULL
are	NULL
boxed	NULL
(	NULL
adapted	NULL
from	NULL
mEKLF	NULL
-	NULL
RSCELCH-	NULL
--	NULL
-	NULL
-	NULL
-	NULL
--	NULL
-	NULL
Pavletich	NULL
and	NULL
Pabo	NULL
1991	NULL
)	NULL
.	NULL

Large	NULL
rectangles	NULL
p	NULL
include	NULL
all	NULL
of	NULL
the	NULL
amino	NULL
acids	NULL
that	NULL
are	NULL
.	NULL

ans	NULL
-	NULL
known	NULL
to	NULL
make	NULL
base	NULL
contacts	NULL
;	NULL
the	NULL
shading	NULL
Factor	NULL
:	NULL
has	NULL
r	NULL
Re	NULL
mse	NULL
?	NULL

mop	NULL
?	NULL

n	NULL
'	NULL
E-lF	NULL
[	NULL
mERLE	NULL
indicates	NULL
residues	NULL
that	NULL
are	NULL
thought	NULL
to	NULL
be	NULL
-on	NULL
)	NULL
___	NULL
ih	NULL
noun	NULL
)	NULL
___	NULL
___	NULL
meni	NULL
__	NULL
particularly	NULL
important	NULL
for	NULL
binding	NULL
site	NULL
rec-	NULL
%	NULL
A	NULL
im	NULL
ognition	NULL
.	NULL

Amino	NULL
acid	NULL
substitutions	NULL
in	NULL
fin-ist	NULL
»	NULL
``	NULL
n	NULL
|	NULL
cag	NULL
i-	NULL
«	NULL
-	NULL
wie	NULL
aam	NULL
|	NULL
gers	NULL
1	NULL
and	NULL
3	NULL
of	NULL
Sp1	NULL
are	NULL
underlined	NULL
and	NULL
bold	NULL
ree	NULL
-w	NULL
|	NULL
Moan	NULL
Imo	NULL
juas	NULL
(	NULL
no	NULL
(	NULL
elt	NULL
lae	NULL
(	NULL
at	NULL
nolaal	NULL
=	NULL
fla	NULL
=	NULL
w	NULL
Wl	NULL
io	NULL
(	NULL
ns	NULL
(	NULL
mSp1	NULL
)	NULL
.	NULL

The	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
8	NULL
EKLF	NULL
zinc	NULL
fingers	NULL
is	NULL
shown	NULL
below	NULL
.	NULL

Resi-Test	NULL
wector	NULL
:	NULL
-	NULL
OMEC-ct	NULL
-	NULL
OVEC-mt	NULL
-	NULL
OVECGct	NULL
_	NULL
OMEC-mt	NULL
CNEC-ct	NULL
_	NULL
OMEC-mt	NULL
dues	NULL
identical	NULL
to	NULL
those	NULL
found	NULL
in	NULL
Spl	NULL
are	NULL
indicated	NULL
by	NULL
dashes	NULL
.	NULL

Amino	NULL
acid	NULL
substitu-=	NULL
tions	NULL
in	NULL
fingers	NULL
1	NULL
and	NULL
3	NULL
of	NULL
EKLF	NULL
are	NULL
under-14	NULL
,	NULL
O	NULL
sess	NULL
P	NULL
E	NULL
©	NULL
&	NULL
2	NULL
:	NULL
lined	NULL
and	NULL
bold	NULL
(	NULL
mEKLF	NULL
)	NULL
Unchanged	NULL
resi-wExuF	NULL
ope	NULL
LLL	NULL
TGM	NULL
l+	NULL
wen	NULL
-	NULL
dues	NULL
are	NULL
indicated	NULL
by	NULL
dots	NULL
.	NULL

(	NULL
B	NULL
)	NULL
mSpl	NULL
and	NULL
mEKLF	NULL
are	NULL
functional	NULL
transcriptional	NULL
acti-	NULL
-pe	NULL
|	NULL
mas	NULL
mmm	NULL
meee	NULL
man	NULL
men	NULL
mend	NULL
-	NULL
CAH	NULL
vators	NULL
.	NULL

CHO	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
OVEC	NULL
test	NULL
vector	NULL
containing	NULL
either	NULL
the	NULL
control	NULL
(	NULL
OVEC-ct	NULL
)	NULL
or	NULL
the	NULL
mutant	NULL
B	NULL
ta	NULL
(	NULL
OVEC-mt	NULL
)	NULL
binding	NULL
site	NULL
,	NULL
0.15	NULL
ug	NULL
of	NULL
OVEC	NULL
reference	NULL
vector	NULL
and	NULL
0.1	NULL
,	NULL
0.5	NULL
,	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
indicated	NULL
pRe/CMV	NULL
expression	NULL
vector	NULL
(	NULL
factor	NULL
)	NULL
.	NULL

After	NULL
72	NULL
hr	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
RN	NULL
A	NULL
synthesized	NULL
from	NULL
the	NULL
OVEC	NULL
vectors	NULL
was	NULL
analyzed	NULL
by	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
(	NULL
Westin	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

The	NULL
RNA	NULL
probe	NULL
detects	NULL
the	NULL
signals	NULL
of	NULL
both	NULL
the	NULL
reference	NULL
and	NULL
test	NULL
vector	NULL
;	NULL
these	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
(	NULL
ref	NULL
and	NULL
test	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Schematic	NULL
drawing	NULL
of	NULL
the	NULL
pEV3	NULL
vector	NULL
used	NULL
to	NULL
express	NULL
transcription	NULL
factors	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

The	NULL
cDNAs	NULL
encoding	NULL
Sp1	NULL
,	NULL
m	NULL
Spl	NULL
,	NULL
EKLF	NULL
,	NULL
and	NULL
mEKLF	NULL
were	NULL
inserted	NULL
in	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
a	NULL
modified	NULL
B-globin	NULL
gene	NULL
.	NULL

Erythroid-specific	NULL
expression	NULL
is	NULL
driven	NULL
by	NULL
a	NULL
6.5-kb	NULL
version	NULL
of	NULL
the	NULL
LCR	NULL
(	NULL
uLCR	NULL
;	NULL
Talbot	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

The	NULL
#	NULL
k-nreo	NULL
gene	NULL
is	NULL
used	NULL
for	NULL
selection	NULL
of	NULL
stably	NULL
transfected	NULL
MEL	NULL
cells	NULL
.	NULL

The	NULL
AaflI	NULL
and	NULL
Asp718	NULL
restriction	NULL
sites	NULL
were	NULL
used	NULL
to	NULL
isolate	NULL
the	NULL
microinjection	NULL
fragment	NULL
for	NULL
transgenesis	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
transcription	NULL
factor	NULL
expression	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
made	NULL
of	NULL
E13.5	NULL
livers	NULL
with	NULL
the	NULL
indicated	NULL
pEV	NULL
transgene	NULL
;	NULL
(	NULL
ntg	NULL
)	NULL
Nontransgenic	NULL
fetal	NULL
liver	NULL
.	NULL

Twenty	NULL
micrograms	NULL
of	NULL
protein	NULL
was	NULL
used	NULL
for	NULL
Western	NULL
blotting	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
anti-EKLF	NULL
(	NULL
fop	NULL
left	NULL
)	NULL
or	NULL
anti-Sp1	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
(	NULL
fop	NULL
right	NULL
)	NULL
.	NULL

As	NULL
a	NULL
loading	NULL
control	NULL
,	NULL
they	NULL
were	NULL
reprobed	NULL
with	NULL
an	NULL
anti-GATA-1	NULL
rat	NULL
monoclonal	NULL
antibody	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

(	NULL
Bottom	NULL
)	NULL
Relative	NULL
levels	NULL
of	NULL
EKLF	NULL
and	NULL
Spl	NULL
as	NULL
determined	NULL
by	NULL
densitometric	NULL
scanning	NULL
of	NULL
the	NULL
autoradiographs	NULL
and	NULL
normalized	NULL
to	NULL
the	NULL
GATA-1	NULL
loading	NULL
control	NULL
(	NULL
ntg	NULL
=1	NULL
)	NULL
.	NULL

GENES	NULL
&	NULL
DEVELOPMENT	NULL
2865	NULL
Gillemans	NULL
et	NULL
al	NULL
.	NULL

dependent	NULL
manner	NULL
.	NULL

We	NULL
inserted	NULL
the	NULL
control	NULL
and	NULL
mutant	NULL
binding	NULL
site	NULL
20	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
OVEC	NULL
test	NULL
vector	NULL
(	NULL
Westin	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
to	NULL
assess	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
factors	NULL
to	NULL
act	NULL
as	NULL
classical	NULL
transcriptional	NULL
transactivators	NULL
.	NULL

The	NULL
cDNAs	NULL
encoding	NULL
the	NULL
factors	NULL
were	NULL
cloned	NULL
in	NULL
the	NULL
expression	NULL
vector	NULL
pRe/CMV	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
cotransfected	NULL
in	NULL
CHO	NULL
cells	NULL
with	NULL
the	NULL
OVEC	NULL
test	NULL
vectors	NULL
and	NULL
the	NULL
OVEC-REF	NULL
vector	NULL
,	NULL
which	NULL
serves	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
72	NULL
hr	NULL
after	NULL
transfection	NULL
,	NULL
and	NULL
the	NULL
RN	NULL
A	NULL
synthesized	NULL
from	NULL
the	NULL
OVEC	NULL
test-	NULL
and	NULL
OVEC-REF	NULL
vectors	NULL
was	NULL
quantitated	NULL
by	NULL
RNase	NULL
protection	NULL
analysis	NULL
(	NULL
Westin	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

This	NULL
shows	NULL
that	NULL
increasing	NULL
the	NULL
amount	NULL
of	NULL
mSpl	NULL
stimulates	NULL
transcription	NULL
of	NULL
the	NULL
OVEC	NULL
vector	NULL
with	NULL
the	NULL
mutant	NULL
binding	NULL
site	NULL
(	NULL
OVEC-mt	NULL
;	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
but	NULL
not	NULL
of	NULL
the	NULL
OVEC	NULL
vector	NULL
with	NULL
the	NULL
control	NULL
binding	NULL
site	NULL
(	NULL
O	NULL
VEC	NULL
-ct	NULL
;	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
Spl	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
transcription	NULL
of	NULL
the	NULL
OVEC-mt	NULL
construct	NULL
but	NULL
stimulates	NULL
transcription	NULL
of	NULL
the	NULL
OVEC-ct	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Transactivation	NULL
by	NULL
Spl	NULL
appears	NULL
to	NULL
be	NULL
less	NULL
effective	NULL
than	NULL
that	NULL
observed	NULL
with	NULL
mSp1	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
most	NULL
likely	NULL
because	NULL
of	NULL
competition	NULL
with	NULL
transcriptional	NULL
repressors	NULL
like	NULL
Sp3	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
control	NULL
sequence	NULL
but	NULL
not	NULL
the	NULL
mutant	NULL
sequence	NULL
(	NULL
Hagen	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
)	NULL
.	NULL

A	NULL
very	NULL
similar	NULL
result	NULL
is	NULL
obtained	NULL
with	NULL
m	NULL
EKLEF	NULL
transactivation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
altered	NULL
DNA-binding	NULL
specificity	NULL
mutants	NULL
of	NULL
EKLF	NULL
and	NULL
Spl	NULL
are	NULL
functional	NULL
transcriptional	NULL
activators	NULL
that	NULL
can	NULL
stimulate	NULL
transcription	NULL
through	NULL
the	NULL
mutant	NULL
fp	NULL
2	NULL
sequence	NULL
in	NULL
vivo	NULL
.	NULL

Erythroid-specific	NULL
expression	NULL
and	NULL
DNA-binding	NULL
properties	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
To	NULL
express	NULL
the	NULL
transcription	NULL
factors	NULL
in	NULL
red	NULL
cells	NULL
,	NULL
we	NULL
cloned	NULL
cDNAs	NULL
encoding	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
proteins	NULL
in	NULL
the	NULL
erythroid-specific	NULL
expression	NULL
vector	NULL
pEV3	NULL
(	NULL
Needham	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
Sp1-pEV	NULL
,	NULL
m	NULL
Sp1-pEV	NULL
,	NULL
EKLE-pEV	NULL
,	NULL
and	NULL
m	NULL
EKLFE-pEV	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Murine	NULL
erythro-leukaemia	NULL
(	NULL
MEL	NULL
)	NULL
cells	NULL
were	NULL
stably	NULL
transfected	NULL
with	NULL
these	NULL
constructs	NULL
to	NULL
check	NULL
for	NULL
the	NULL
expression	NULL
and	NULL
DN	NULL
A-binding	NULL
properties	NULL
of	NULL
the	NULL
transgene-derived	NULL
transcription	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
they	NULL
were	NULL
then	NULL
used	NULL
to	NULL
generate	NULL
transgenic	NULL
mice	NULL
.	NULL

For	NULL
each	NULL
construct	NULL
,	NULL
one	NULL
transgenic	NULL
line	NULL
was	NULL
analyzed	NULL
further	NULL
;	NULL
these	NULL
lines	NULL
will	NULL
be	NULL
referred	NULL
to	NULL
as	NULL
Sp1l-pEV	NULL
,	NULL
m	NULL
Sp1l-pEV	NULL
,	NULL
EKLF-pEV	NULL
,	NULL
and	NULL
m	NULL
EKLF-pEV	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
of	NULL
transgene-derived	NULL
transcription	NULL
factors	NULL
were	NULL
assessed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
E13.5	NULL
fetal	NULL
liver	NULL
extracts	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
rabbit	NULL
polyclonal	NULL
antisera	NULL
directed	NULL
against	NULL
EKLF	NULL
or	NULL
Sp1	NULL
.	NULL

The	NULL
epitopes	NULL
recognized	NULL
by	NULL
these	NULL
antibodies	NULL
are	NULL
amino-terminal	NULL
to	NULL
the	NULL
zinc	NULL
finger	NULL
domains	NULL
and	NULL
they	NULL
therefore	NULL
detect	NULL
both	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
transcription	NULL
factors	NULL
.	NULL

As	NULL
a	NULL
loading	NULL
control	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
reprobed	NULL
with	NULL
a	NULL
rat	NULL
monoclonal	NULL
antibody	NULL
specific	NULL
for	NULL
the	NULL
erythroid-specific	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
transgene-derived	NULL
transcription	NULL
factors	NULL
are	NULL
comparable	NULL
to	NULL
those	NULL
of	NULL
the	NULL
endogenous	NULL
factors	NULL
,	NULL
as	NULL
we	NULL
observe	NULL
a	NULL
moderate	NULL
(	NULL
approximately	NULL
two-fold	NULL
)	NULL
increase	NULL
of	NULL
the	NULL
signals	NULL
in	NULL
the	NULL
transgenic	NULL
samples	NULL
,	NULL
Figure	NULL
3	NULL
.	NULL

Gel	NULL
retardation	NULL
analysis	NULL
of	NULL
Spl	NULL
-	NULL
A	NULL
2	NULL
oB	NULL
4g	NULL
B	NULL
Extract	NULL
_	NULL
mEKLF	NULL
mep	NULL
Sp1	NULL
family	NULL
members	NULL
binding	NULL
to	NULL
the	NULL
mutant	NULL
fp	NULL
2	NULL
Extract	NULL
&	NULL
€	NULL
&	NULL
%	NULL
Exess	NULL
binding	NULL
site	NULL
.	NULL

(	NULL
4A	NULL
)	NULL
Extracts	NULL
were	NULL
made	NULL
from	NULL
S91	NULL
_	NULL
,	NULL
|	NULL
Comp	NULL
.	NULL

l	NULL
ooh	NULL
:	NULL
_	NULL
Eat-ii	NULL
if	NULL
:	NULL
_	NULL
‘	NULL
E	NULL
‘	NULL
E	NULL
if	NULL
:	NULL
Eg	NULL
‘	NULL
_E	NULL
12—5	NULL
:	NULL
£-1	NULL
;	NULL
de	NULL
ceclils	NULL
gralnsfgiyefdn	NULL
INith	NULL
IpEV3,2	NULL
FEKLF	NULL
}	NULL
Sp3	NULL
-*	NULL
laa	NULL
[	NULL
a-	NULL
tct	NULL
ti	NULL
ime	NULL
omits	NULL
tts	NULL
,	NULL
me	NULL
coon	NULL
gm	NULL
aat	NULL
pl-	NULL
,	NULL
and	NULL
m	NULL
Sp1-pEV	NULL
.	NULL

anes	NULL
I	NULL
and	NULL
2	NULL
,	NULL
2	NULL
ug	NULL
o	NULL
.	NULL

extract	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
control	NULL
fp	NULL
2	NULL
Sp3	NULL
-+	NULL
|	NULL
El	NULL
``	NULL
:	NULL
``	NULL
``	NULL
H	NULL
``	NULL
Sh1=ts|	NULL
probe	NULL
(	NULL
ct	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
4	NULL
ug	NULL
of	NULL
BKLF	NULL
-	NULL
»	NULL
msgi	NULL
-	NULL
»	NULL
(	NULL
an	NULL
extract	NULL
was	NULL
used	NULL
.	NULL

These	NULL
reactions	NULL
contained	NULL
a	NULL
fivefold	NULL
molar	NULL
excess	NULL
of	NULL
Spl	NULL
competitor	NULL
oli-	NULL
EKLF	NULL
-	NULL
»	NULL
i	NULL
|	NULL
gonucleotide	NULL
to	NULL
reduce	NULL
the	NULL
background	NULL
|	NULL
I	NULL
caused	NULL
by	NULL
Spl	NULL
family	NULL
members	NULL
that	NULL
bind	NULL
1	NULL
:	NULL
3	NULL
4	NULL
|	NULL
more	NULL
avidly	NULL
to	NULL
GC	NULL
than	NULL
to	NULL
GT	NULL
boxes	NULL
.	NULL

The	NULL
Probe	NULL
cf	NULL
fp	NULL
?	NULL

binding	NULL
reactions	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
4	NULL
%	NULL
PAA/O.5	NULL
%	NULL
TEE	NULL
gel	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
bands	NULL
C	NULL
-	NULL
Comp	NULL
:	NULL
-	NULL
ctfp2	NULL
corresponding	NULL
to	NULL
Sp1	NULL
,	NULL
Sp3	NULL
,	NULL
BKLF	NULL
,	NULL
and	NULL
EKLF	NULL
_u	NULL
_d	NULL
are	NULL
indicated	NULL
(	NULL
see	NULL
Crossley	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
;	NULL
Marin	NULL
|	NULL
|	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Extracts	NULL
were	NULL
made	NULL
from	NULL
fetal	NULL
mep1	NULL
-	NULL
»	NULL
|	NULL
.	NULL

-ﬂ	NULL
livers	NULL
transgenic	NULL
for	NULL
Sp1-	NULL
,	NULL
m	NULL
Sp1-	NULL
,	NULL
or	NULL
m	NULL
EKLE-pEV	NULL
.	NULL

In	NULL
lanes	NULL
1-6	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
mutant	NULL
fp	NULL
2	NULL
probe	NULL
(	NULL
mt	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

mEXLF	NULL
-	NULL
»	NULL
#	NULL
1	NULL
)	NULL
.	NULL

In	NULL
lanes	NULL
7-12	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
extract	NULL
was	NULL
used	NULL
,	NULL
and	NULL
in	NULL
lanes	NULL
13-17	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
extract	NULL
was	NULL
added	NULL
to	NULL
1	NULL
2	NULL
3	NULL
1	NULL
5	NULL
6	NULL
r	NULL
Probe	NULL
:	NULL
mt	NULL
fo2	NULL
the	NULL
reactions	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
reactions	NULL
contained	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
mutant	NULL
fp	NULL
2	NULL
double-stranded	NULL
competitor	NULL
oligonucleotide	NULL
(	NULL
mt	NULL
fp2	NULL
;	NULL
lanes	NULL
2,8	NULL
,	NULL
/4	NULL
)	NULL
or	NULL
control	NULL
fp2	NULL
control	NULL
competitor	NULL
(	NULL
ct	NULL
fp2	NULL
;	NULL
lanes	NULL
3,9	NULL
)	NULL
,	NULL
or	NULL
antibodies	NULL
directed	NULL
against	NULL
Sp3	NULL
(	NULL
aSp3	NULL
;	NULL
lanes	NULL
4,10,15	NULL
)	NULL
,	NULL
EKLF	NULL
(	NULL
@	NULL
«	NULL
EKLF	NULL
;	NULL
lanes	NULL
5,11,16	NULL
)	NULL
and	NULL
Sp1	NULL
(	NULL
«	NULL
Spl	NULL
;	NULL
lanes	NULL
6,12,17	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
m	NULL
EKLF	NULL
,	NULL
mSp1	NULL
,	NULL
and	NULL
the	NULL
free	NULL
probe	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
;	NULL
a	NULL
vertical	NULL
bar	NULL
denotes	NULL
the	NULL
positions	NULL
of	NULL
supershifts	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
antibody	NULL
.	NULL

Apparent	NULL
degradation	NULL
products	NULL
of	NULL
m	NULL
EKLF	NULL
are	NULL
marked	NULL
with	NULL
an	NULL
asterisk	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Binding	NULL
specificity	NULL
of	NULL
m	NULL
Spl	NULL
and	NULL
m	NULL
EKLF	NULL
to	NULL
the	NULL
mutant	NULL
fp	NULL
2	NULL
sequence	NULL
.	NULL

Two	NULL
microgram	NULL
s	NULL
of	NULL
m	NULL
§p1-pEV	NULL
or	NULL
4	NULL
ug	NULL
of	NULL
m	NULL
EKLF-pEV	NULL
fetal	NULL
liver	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
mutant	NULL
fp	NULL
2	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
cold	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

(	NULL
Lane	NULL
/	NULL
)	NULL
No	NULL
competitor	NULL
added	NULL
;	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
2-	NULL
,	NULL
10-	NULL
,	NULL
and	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
mutant	NULL
fp	NULL
2	NULL
competitor	NULL
;	NULL
(	NULL
lanes	NULL
5-7	NULL
)	NULL
2-	NULL
,	NULL
10-	NULL
,	NULL
and	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
control	NULL
fp	NULL
2	NULL
competitor	NULL
,	NULL
respectively	NULL
.	NULL

2866	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
relative	NULL
to	NULL
the	NULL
GATA-1	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
transgene-derived	NULL
transcription	NULL
factors	NULL
are	NULL
expressed	NULL
at	NULL
physiological	NULL
levels	NULL
,	NULL
thus	NULL
allowing	NULL
comparison	NULL
of	NULL
the	NULL
biological	NULL
effects	NULL
of	NULL
these	NULL
factors	NULL
.	NULL

Protein	NULL
extracts	NULL
derived	NULL
from	NULL
transfected	NULL
MEL	NULL
cells	NULL
and	NULL
E13.5	NULL
transgenic	NULL
livers	NULL
were	NULL
used	NULL
for	NULL
gel	NULL
retardation	NULL
analysis	NULL
with	NULL
oligonucleotide	NULL
probes	NULL
containing	NULL
the	NULL
control	NULL
or	NULL
the	NULL
mutant	NULL
fp	NULL
2	NULL
sequence	NULL
.	NULL

Transfected	NULL
MEL	NULL
cell	NULL
extracts	NULL
show	NULL
that	NULL
transgene-derived	NULL
Spl	NULL
and	NULL
EKLF	NULL
proteins	NULL
bind	NULL
to	NULL
the	NULL
control	NULL
fp	NULL
2	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
;	NULL
this	NULL
could	NULL
not	NULL
be	NULL
demonstrated	NULL
in	NULL
fetal	NULL
liver	NULL
extracts	NULL
because	NULL
of	NULL
the	NULL
large	NULL
background	NULL
caused	NULL
by	NULL
other	NULL
proteins	NULL
present	NULL
in	NULL
these	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Very	NULL
little	NULL
,	NULL
if	NULL
any	NULL
,	NULL
specific	NULL
binding	NULL
to	NULL
the	NULL
mutant	NULL
fp	NULL
2	NULL
oligonucleotide	NULL
is	NULL
observed	NULL
with	NULL
extracts	NULL
from	NULL
Sp1l-pEV	NULL
fetal	NULL
livers	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
or	NULL
with	NULL
extracts	NULL
from	NULL
EKLEF-pEV	NULL
and	NULL
nontransgenic	NULL
livers	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Sp1	NULL
family	NULL
members	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
interact	NULL
efficiently	NULL
with	NULL
the	NULL
mutant	NULL
sequence	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
functional	NULL
data	NULL
obtained	NULL
in	NULL
transgenic	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
and	NULL
CHO	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
transgene-derived	NULL
m	NULL
Sp1	NULL
and	NULL
m	NULL
EKLF	NULL
proteins	NULL
do	NULL
interact	NULL
with	NULL
the	NULL
mutant	NULL
fp	NULL
2	NULL
sequence	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
these	NULL
interactions	NULL
is	NULL
demonstrated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
competitor	NULL
oligonucleotides	NULL
and	NULL
antibodies	NULL
to	NULL
the	NULL
reactions	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
mEKLF	NULL
and	NULL
mSpl	NULL
bind	NULL
specifically	NULL
to	NULL
the	NULL
mutant	NULL
fp	NULL
2	NULL
sequence	NULL
in	NULL
vitro	NULL
and	NULL
not	NULL
to	NULL
the	NULL
control	NULL
fp	NULL
2	NULL
sequence	NULL
,	NULL
whereas	NULL
the	NULL
opposite	NULL
is	NULL
true	NULL
for	NULL
wild-type	NULL
EKLF	NULL
and	NULL
Spl	NULL
.	NULL

Functional	NULL
analysis	NULL
in	NULL
transgenic	NULL
mice	NULL
To	NULL
analyze	NULL
the	NULL
effect	NULL
of	NULL
EKLF	NULL
and	NULL
Spl	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
fp	NULL
1-3	NULL
constructs	NULL
in	NULL
transgenic	NULL
mice	NULL
,	NULL
we	NULL
generated	NULL
reporter	NULL
mice	NULL
with	NULL
the	NULL
control	NULL
or	NULL
the	NULL
mutant	NULL
fp	NULL
1-3	NULL
fragment	NULL
driving	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
gene	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

For	NULL
each	NULL
construct	NULL
,	NULL
two	NULL
independent	NULL
lines	NULL
were	NULL
established	NULL
.	NULL

These	NULL
lines	NULL
were	NULL
crossed	NULL
with	NULL
the	NULL
Sp1-pEV	NULL
,	NULL
mSpl-pEV	NULL
,	NULL
EKLE-pEV	NULL
,	NULL
and	NULL
m	NULL
EKLE-pEV	NULL
lines	NULL
,	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
transgene-derived	NULL
transcription	NULL
factors	NULL
on	NULL
human	NULL
B-globin	NULL
gene	NULL
expression	NULL
was	NULL
determined	NULL
by	NULL
quantitative	NULL
S1	NULL
nuclease	NULL
protection	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
mouse	NULL
-globin	NULL
mRNA	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
control	NULL
reporter	NULL
gene	NULL
is	NULL
not	NULL
altered	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
Sp/I-pEV	NULL
,	NULL
m	NULL
Sp/I-pEV	NULL
,	NULL
EK-LFE-pEV	NULL
,	NULL
or	NULL
m	NULL
EKLF-pEV	NULL
transgenes	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
transgene-derived	NULL
transcription	NULL
factors	NULL
have	NULL
no	NULL
influence	NULL
on	NULL
the	NULL
control	NULL
reporter	NULL
gene	NULL
,	NULL
excluding	NULL
the	NULL
possibility	NULL
of	NULL
a	NULL
dominant	NULL
effect	NULL
on	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
mutant	NULL
reporter	NULL
gene	NULL
are	NULL
affected	NULL
by	NULL
m	NULL
EKLF	NULL
,	NULL
but	NULL
not	NULL
by	NULL
Spl	NULL
,	NULL
mSpl	NULL
,	NULL
and	NULL
EKLF	NULL
.	NULL

This	NULL
demonstrates	NULL
that	NULL
the	NULL
observed	NULL
differences	NULL
are	NULL
dependent	NULL
on	NULL
the	NULL
altered	NULL
zinc	NULL
finger	NULL
domains	NULL
of	NULL
mEKLF	NULL
and	NULL
that	NULL
the	NULL
effect	NULL
is	NULL
specific	NULL
to	NULL
EKLF	NULL
,	NULL
as	NULL
mSpl	NULL
has	NULL
no	NULL
influence	NULL
on	NULL
the	NULL
mutant	NULL
reporter	NULL
gene	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
mutant	NULL
reporter	NULL
gene	NULL
is	NULL
increased	NULL
threefold	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
m	NULL
EKLF	NULL
,	NULL
approaching	NULL
the	NULL
level	NULL
observed	NULL
with	NULL
the	NULL
control	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

From	NULL
this	NULL
we	NULL
conclude	NULL
that	NULL
EKLF	NULL
directly	NULL
activates	NULL
5'HS3	NULL
by	NULL
binding	NULL
to	NULL
fp	NULL
2	NULL
in	NULL
vivo	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
mSpl1	NULL
protein	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
B-globin	NULL
gene	NULL
expression	NULL
through	NULL
fp	NULL
2	NULL
of	NULL
5'HS3	NULL
,	NULL
even	NULL
EKLF	NULL
but	NULL
not	NULL
Sp1	NULL
is	NULL
an	NULL
activator	NULL
of	NULL
the	NULL
LCR	NULL
5	NULL
C	NULL
-	NULL
&	NULL
3	NULL
Z	NULL
-	NULL
R	NULL
5	NULL
C	NULL
alls	NULL
a	NULL
©	NULL
x	NULL
d	NULL
a	NULL
©	NULL
z	NULL
W	NULL
Transcrpbon	NULL
factor	NULL
.	NULL

-	NULL
-	NULL
0	NULL
=	NULL
uw	NULL
£	NULL
-	NULL
-a	NULL
E	NULL
w	NULL
E	NULL
3x	NULL
mo-	NULL
-	NULL
U	NULL
I'PE—b-	NULL
-	NULL
(	NULL
a	NULL
seu	NULL
mms	NULL
sna	NULL
mes	NULL
mans	NULL
mms	NULL
mat	NULL
To	NULL
&	NULL
8	NULL
%	NULL
11	NULL
12	NULL
43	NULL
Reporter	NULL
construct	NULL
mutant	NULL
control	NULL
Figure	NULL
4	NULL
.	NULL

Quantitative	NULL
S1	NULL
nuclease	NULL
protection	NULL
assay	NULL
of	NULL
human	NULL
B-globin	NULL
transgene	NULL
expression	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
from	NULL
E13.5	NULL
fetal	NULL
livers	NULL
containing	NULL
the	NULL
mutant	NULL
or	NULL
the	NULL
control	NULL
B-globin	NULL
reporter	NULL
construct	NULL
and	NULL
the	NULL
Sp1-	NULL
,	NULL
mSpl-	NULL
,	NULL
EKLF-	NULL
,	NULL
or	NULL
mEKLF-pEV	NULL
transgenes	NULL
as	NULL
indicated	NULL
.	NULL

One	NULL
microgram	NULL
of	NULL
RNA	NULL
was	NULL
used	NULL
for	NULL
the	NULL
S1	NULL
nuclease	NULL
protection	NULL
assay	NULL
with	NULL
probes	NULL
detecting	NULL
endogenous	NULL
mouse	NULL
«	NULL
-globin	NULL
mRNA	NULL
(	NULL
m-a	NULL
)	NULL
and	NULL
human	NULL
B-globin	NULL
mRNA	NULL
(	NULL
h-B	NULL
)	NULL
.	NULL

An	NULL
increased	NULL
level	NULL
of	NULL
human	NULL
B-globin	NULL
mRNA	NULL
is	NULL
only	NULL
observed	NULL
for	NULL
the	NULL
mutant	NULL
reporter	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
m	NULL
EKLF	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
;	NULL
no	NULL
changes	NULL
are	NULL
found	NULL
in	NULL
any	NULL
of	NULL
the	NULL
other	NULL
combinations	NULL
.	NULL

Lane	NULL
13	NULL
contains	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
RNA	NULL
sample	NULL
used	NULL
in	NULL
lane	NULL
7	NULL
to	NULL
demonstrate	NULL
probe	NULL
excess	NULL
.	NULL

though	NULL
it	NULL
is	NULL
a	NULL
functional	NULL
activator	NULL
when	NULL
the	NULL
mutant	NULL
binding	NULL
site	NULL
is	NULL
placed	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
OVEC	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
specific	NULL
combination	NULL
of	NULL
GATA-1	NULL
bound	NULL
at	NULL
fp	NULL
1	NULL
and	NULL
3	NULL
and	NULL
EKLF	NULL
bound	NULL
at	NULL
fp	NULL
2	NULL
is	NULL
required	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
5'HS3	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Analysis	NULL
of	NULL
reporter	NULL
gene	NULL
expression	NULL
at	NULL
the	NULL
single	NULL
cell	NULL
level	NULL
The	NULL
S1	NULL
nuclease	NULL
protection	NULL
assay	NULL
described	NULL
above	NULL
provides	NULL
a	NULL
quantitative	NULL
measurement	NULL
of	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
populations	NULL
of	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
reporter	NULL
gene	NULL
might	NULL
be	NULL
expressed	NULL
at	NULL
a	NULL
high	NULL
level	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
the	NULL
cells	NULL
and	NULL
not	NULL
in	NULL
the	NULL
remaining	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
scenario	NULL
,	NULL
m	NULL
EKLF	NULL
would	NULL
act	NULL
by	NULL
increasing	NULL
the	NULL
fraction	NULL
of	NULL
cells	NULL
expressing	NULL
the	NULL
mutant	NULL
reporter	NULL
gene	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
reporter	NULL
gene	NULL
might	NULL
be	NULL
expressed	NULL
in	NULL
the	NULL
large	NULL
majority	NULL
of	NULL
erythroid	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
case	NULL
m	NULL
EKLF	NULL
could	NULL
exert	NULL
its	NULL
effect	NULL
by	NULL
increasing	NULL
the	NULL
rate	NULL
and/or	NULL
the	NULL
duration	NULL
of	NULL
active	NULL
transcription	NULL
of	NULL
the	NULL
mutant	NULL
reporter	NULL
gene	NULL
(	NULL
Milot	NULL
et	NULL
al	NULL
.	NULL

Table	NULL
1	NULL
.	NULL

Expression	NULL
levels	NULL
of	NULL
human	NULL
B-globin	NULL
m	NULL
RNA	NULL
in	NULL
E13.5	NULL
fetal	NULL
liver	NULL
cells	NULL
of	NULL
reporter/transcription	NULL
factor	NULL
transgenic	NULL
lines	NULL
Reporter	NULL
transgene	NULL
(	NULL
copy	NULL
no	NULL
.	NULL
)	NULL

pEV	NULL
control	NULL
control	NULL
mutant	NULL
mutant	NULL
transgene	NULL
line	NULL
1	NULL
(	NULL
5	NULL
)	NULL
line	NULL
2	NULL
(	NULL
17	NULL
)	NULL
line	NULL
1	NULL
(	NULL
7	NULL
)	NULL
line	NULL
2	NULL
(	NULL
4	NULL
)	NULL
None	NULL
56	NULL
40	NULL
15	NULL
11	NULL
Spl	NULL
55	NULL
42	NULL
14	NULL
10	NULL
m	NULL
Sp	NULL
I	NULL
55	NULL
42	NULL
16	NULL
11	NULL
EKLF	NULL
55	NULL
40	NULL
15	NULL
11	NULL
m	NULL
EKLF	NULL
54	NULL
41	NULL
43	NULL
32	NULL
Expression	NULL
of	NULL
the	NULL
reporter	NULL
genes	NULL
was	NULL
calculated	NULL
as	NULL
the	NULL
ratio	NULL
of	NULL
human	NULL
B-globin	NULL
to	NULL
mouse	NULL
«	NULL
-globin	NULL
signals	NULL
,	NULL
corrected	NULL
for	NULL
transgene	NULL
copy	NULL
num	NULL
ber	NULL
,	NULL
and	NULL
normalized	NULL
to	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
the	NULL
wild-type	NULL
fp	NULL
1-3	NULL
construct	NULL
(	NULL
2100	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

GENES	NULL
&	NULL
DEVELOPMENT	NULL
2867	NULL
Gillemans	NULL
et	NULL
al	NULL
.	NULL

1996b	NULL
)	NULL
.	NULL

To	NULL
distinguish	NULL
between	NULL
these	NULL
possibilities	NULL
,	NULL
we	NULL
analyzed	NULL
reporter	NULL
gene	NULL
expression	NULL
at	NULL
the	NULL
single	NULL
cell	NULL
level	NULL
by	NULL
primary	NULL
transcript	NULL
in	NULL
situ	NULL
hybridization	NULL
(	NULL
Wijgerde	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
probes	NULL
detecting	NULL
nuclear	NULL
transcription	NULL
spots	NULL
of	NULL
the	NULL
endogenous	NULL
a-globin	NULL
genes	NULL
were	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
num	NULL
ber	NULL
of	NULL
erythroid	NULL
cells	NULL
(	NULL
Tewari	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

Human	NULL
-globin	NULL
nuclear	NULL
transcription	NULL
signals	NULL
were	NULL
visualized	NULL
with	NULL
four	NULL
oligonucleotides	NULL
derived	NULL
from	NULL
intron	NULL
1	NULL
;	NULL
as	NULL
two	NULL
of	NULL
these	NULL
probes	NULL
overlap	NULL
partially	NULL
with	NULL
exon	NULL
sequences	NULL
,	NULL
cytoplasmic	NULL
-globin	NULL
mRNA	NULL
can	NULL
also	NULL
be	NULL
detected	NULL
(	NULL
Dillon	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
cytoplasmic	NULL
mRNA	NULL
shows	NULL
that	NULL
a	NULL
cell	NULL
has	NULL
expressed	NULL
the	NULL
transgene	NULL
at	NULL
some	NULL
point	NULL
in	NULL
time	NULL
,	NULL
whereas	NULL
the	NULL
presence	NULL
of	NULL
nuclear	NULL
precursor	NULL
RN	NULL
A	NULL
at	NULL
the	NULL
site	NULL
of	NULL
transcription	NULL
is	NULL
indicative	NULL
of	NULL
active	NULL
transcription	NULL
because	NULL
precursor	NULL
RN	NULL
As	NULL
are	NULL
rapidly	NULL
processed	NULL
(	NULL
Wijgerde	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
this	NULL
analysis	NULL
are	NULL
summarized	NULL
in	NULL
Figure	NULL
5	NULL
and	NULL
Table	NULL
2	NULL
.	NULL

Cells	NULL
expressing	NULL
m	NULL
EKLF	NULL
show	NULL
a	NULL
three-	NULL
to	NULL
fourfold	NULL
increased	NULL
num	NULL
ber	NULL
of	NULL
nuclei	NULL
with	NULL
transcriptional	NULL
foci	NULL
of	NULL
the	NULL
mutant	NULL
reporter	NULL
gene	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
cytoplasm	NULL
of	NULL
the	NULL
cells	NULL
shows	NULL
a	NULL
more	NULL
intense	NULL
red	NULL
staining	NULL
than	NULL
cells	NULL
with	NULL
just	NULL
the	NULL
mutant	NULL
reporter	NULL
construct	NULL
,	NULL
reflecting	NULL
the	NULL
increased	NULL
amounts	NULL
of	NULL
human	NULL
B-globin	NULL
mRNA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
m	NULL
EKLF	NULL
.	NULL

Human	NULL
-globin	NULL
signals	NULL
are	NULL
not	NULL
affected	NULL
if	NULL
m	NULL
Spl	NULL
is	NULL
expressed	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
S1	NULL
nuclease	NULL
analysis	NULL
.	NULL

All	NULL
cells	NULL
with	NULL
the	NULL
control	NULL
reporter	NULL
gene	NULL
contain	NULL
B-globin	NULL
mRNA	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
as	NULL
do	NULL
cells	NULL
with	NULL
the	NULL
mutant	NULL
reporter	NULL
containing	NULL
m	NULL
EKLF	NULL
.	NULL

Expression	NULL
of	NULL
any	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
control	NULL
reporter	NULL
gene	NULL
,	NULL
nor	NULL
does	NULL
expression	NULL
of	NULL
Spl	NULL
or	NULL
EKLF	NULL
have	NULL
any	NULL
effect	NULL
on	NULL
the	NULL
mutant	NULL
reporter	NULL
gene	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
S1	NULL
nuclease	NULL
data	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
in	NULL
situ	NULL
hybridization	NULL
analysis	NULL
shows	NULL
that	NULL
the	NULL
fp	NULL
1-3	NULL
reporter	NULL
transgenic	NULL
lines	NULL
used	NULL
in	NULL
this	NULL
study	NULL
do	NULL
not	NULL
show	NULL
classical	NULL
position	NULL
effect	NULL
variegation	NULL
.	NULL

Such	NULL
effects	NULL
can	NULL
be	NULL
observed	NULL
when	NULL
LCR	NULL
mutants	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
70-kb	NULL
B-globin	NULL
locus	NULL
are	NULL
integrated	NULL
in	NULL
heterochromatic	NULL
regions	NULL
(	NULL
Milot	NULL
et	NULL
al	NULL
.	NULL

1996b	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
we	NULL
observe	NULL
primary	NULL
transcription	NULL
signals	NULL
in	NULL
only	NULL
part	NULL
of	NULL
the	NULL
cells	NULL
shows	NULL
that	NULL
transcription	NULL
of	NULL
the	NULL
reporter	NULL
genes	NULL
is	NULL
discon-tinuous	NULL
.	NULL

Importantly	NULL
,	NULL
mEKLF	NULL
appears	NULL
to	NULL
activate	NULL
the	NULL
mutant	NULL
reporter	NULL
gene	NULL
in	NULL
all	NULL
cells	NULL
because	NULL
the	NULL
cytoplasmic	NULL
staining	NULL
increases	NULL
in	NULL
all	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Reporter	NULL
construct	NULL
:	NULL
Transcription	NULL
factor	NULL
:	NULL
Figure	NULL
5	NULL
.	NULL

Primary	NULL
transcript	NULL
in	NULL
situ	NULL
hybridization	NULL
detecting	NULL
human	NULL
B-globin	NULL
and	NULL
mouse	NULL
«	NULL
-globin	NULL
transcription	NULL
.	NULL

E13.5	NULL
fetal	NULL
liver	NULL
cells	NULL
with	NULL
the	NULL
indicated	NULL
transgene	NULL
makeup	NULL
(	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
were	NULL
disrupted	NULL
in	NULL
PBS	NULL
,	NULL
spotted	NULL
on	NULL
polylysine-coated	NULL
slides	NULL
,	NULL
fixed	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
primary	NULL
transcript	NULL
in	NULL
situ	NULL
hybridization	NULL
with	NULL
two	NULL
sets	NULL
of	NULL
oligonucleotide	NULL
probes	NULL
detecting	NULL
mouse	NULL
«	NULL
-globin	NULL
(	NULL
green	NULL
)	NULL
and	NULL
human	NULL
B-globin	NULL
(	NULL
red	NULL
)	NULL
nuclear	NULL
transcription	NULL
signals	NULL
.	NULL

The	NULL
probes	NULL
for	NULL
human	NULL
B-globin	NULL
also	NULL
detect	NULL
cytoplasmic	NULL
mRNA	NULL
;	NULL
this	NULL
is	NULL
particularly	NULL
evident	NULL
in	NULL
the	NULL
mutant	NULL
reporter/mEKLF	NULL
and	NULL
the	NULL
control	NULL
reporter	NULL
cells	NULL
.	NULL

Representative	NULL
examples	NULL
of	NULL
20	NULL
cells	NULL
are	NULL
shown	NULL
for	NULL
each	NULL
transgene	NULL
combination	NULL
.	NULL

2868	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
factor	NULL
Sp1	NULL
QEFCHEF	NULL
construct	NULL
Table	NULL
2	NULL
.	NULL

Primary	NULL
transcript	NULL
in	NULL
situ	NULL
hybridization	NULL
of	NULL
E13.5	NULL
fetal	NULL
liver	NULL
cells	NULL
from	NULL
reporter/transcription	NULL
factor	NULL
transgenic	NULL
lines	NULL
Reporter	NULL
transgene	NULL
(	NULL
copy	NULL
no	NULL
.	NULL
)	NULL

pEV	NULL
control	NULL
control	NULL
mutant	NULL
mutant	NULL
transgene	NULL
line	NULL
1	NULL
(	NULL
5	NULL
)	NULL
line	NULL
2	NULL
(	NULL
17	NULL
)	NULL
line	NULL
1	NULL
(	NULL
7	NULL
)	NULL
line	NULL
2	NULL
(	NULL
4	NULL
)	NULL
None	NULL
57	NULL
86	NULL
13	NULL
7	NULL
Spl	NULL
59	NULL
N.D.	NULL
14	NULL
8	NULL
m	NULL
Sp	NULL
I	NULL
55	NULL
N.D.	NULL
12	NULL
6	NULL
EKLF	NULL
56	NULL
N.D.	NULL
14	NULL
7	NULL
m	NULL
EKLF	NULL
55	NULL
N.D.	NULL
39	NULL
23	NULL
The	NULL
percentage	NULL
of	NULL
cells	NULL
with	NULL
human	NULL
B-globin	NULL
transcription	NULL
signals	NULL
was	NULL
calculated	NULL
from	NULL
at	NULL
least	NULL
300	NULL
cells	NULL
with	NULL
a-globin	NULL
transcription	NULL
signals	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
for	NULL
each	NULL
data	NULL
point	NULL
.	NULL

The	NULL
error	NULL
margin	NULL
was	NULL
<	NULL
10	NULL
%	NULL
.	NULL

DNase	NULL
I	NULL
hypersensitivity	NULL
analysis	NULL
The	NULL
core	NULL
fragments	NULL
of	NULL
the	NULL
LCR	NULL
coincide	NULL
with	NULL
strong	NULL
,	NULL
erythroid-specific	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
.	NULL

In	NULL
E13.5	NULL
liver	NULL
cells	NULL
of	NULL
the	NULL
reporter	NULL
lines	NULL
a	NULL
hypersensitive	NULL
site	NULL
is	NULL
found	NULL
at	NULL
the	NULL
control	NULL
fp	NULL
1-3	NULL
sequence	NULL
,	NULL
whereas	NULL
a	NULL
weaker	NULL
hypersensitive	NULL
site	NULL
is	NULL
found	NULL
at	NULL
the	NULL
mutant	NULL
fp	NULL
1-3	NULL
sequence	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
binding	NULL
of	NULL
mEKLFE	NULL
to	NULL
the	NULL
mutant	NULL
fp	NULL
1-3	NULL
sequence	NULL
would	NULL
result	NULL
in	NULL
increased	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
,	NULL
nuclei	NULL
isolated	NULL
from	NULL
transgenic	NULL
E13.5	NULL
liver	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
a	NULL
DN	NULL
ase	NULL
I	NULL
fade-out	NULL
analysis	NULL
(	NULL
see	NULL
Ellis	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

Purified	NULL
DNA	NULL
of	NULL
these	NULL
DNase	NULL
I	NULL
series	NULL
was	NULL
digested	NULL
with	NULL
Nco	NULL
!	NULL

and	NULL
Southern	NULL
blotted	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
m	NULL
EKLF	NULL
,	NULL
a	NULL
weak	NULL
hypersensitive	NULL
site	NULL
is	NULL
detectable	NULL
at	NULL
the	NULL
mutant	NULL
fp	NULL
1-3	NULL
area	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
mutant	NULL
)	NULL
;	NULL
hypersensitivity	NULL
is	NULL
increased	NULL
modestly	NULL
in	NULL
the	NULL
compound	NULL
transgenic	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
mutant	NULL
+	NULL
m	NULL
EKLPF	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
for	NULL
DNase	NULL
I	NULL
digestion	NULL
,	NULL
the	NULL
same	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
rehybridized	NULL
with	NULL
a	NULL
probe	NULL
detecting	NULL
a	NULL
0.85-kb	NULL
fragment	NULL
of	NULL
the	NULL
mouse	NULL
a	NULL
,	NULL
-globin	NULL
gene	NULL
,	NULL
as	NULL
DN	NULL
ase	NULL
I	NULL
sensitivity	NULL
of	NULL
this	NULL
gene	NULL
should	NULL
not	NULL
be	NULL
affected	NULL
by	NULL
m	NULL
EKLF	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
bottom	NULL
)	NULL
.	NULL

Quantitation	NULL
of	NULL
the	NULL
signals	NULL
in	NULL
the	NULL
hypersensitive	NULL
site	NULL
area	NULL
relative	NULL
to	NULL
the	NULL
corresponding	NULL
mouse	NULL
a	NULL
,	NULL
-globin	NULL
signals	NULL
indicates	NULL
that	NULL
hypersensitivity	NULL
is	NULL
increased	NULL
two-	NULL
to	NULL
threefold	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
m	NULL
EKLF	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
from	NULL
these	NULL
mutant	NULL
murant	NULL
-	NULL
EKLF	NULL
mEkKLF	NULL
mspi	NULL
mutant	NULL
mutant	NULL
control	NULL
A	NULL
4.3	NULL
kh	NULL
Ncol	NULL
.jfl	NULL
Ncol	NULL
0.9	NULL
kb	NULL
B	NULL
mutant	NULL
mutant	NULL
+	NULL
mEKLF	NULL
[	NULL
TOCOOIT	NULL
COCO	NULL
OI	NULL
[	NULL
DNase	NULL
]	NULL
LAC—4	NULL
wlio	NULL
a	NULL
n	NULL
mn	NULL
.	NULL

@	NULL
n	NULL
n	NULL
|	NULL
+-	NULL
Nicol	NULL
HSL	NULL
M	NULL
<	NULL
-	NULL
Apel-hcol	NULL
1	NULL
2	NULL
34	NULL
56	NULL
7	NULL
2	NULL
3	NULL
456	NULL
T	NULL
&	NULL
-f-	NULL
|	NULL
ai	NULL
ams	NULL
oon	NULL
wn	NULL
(	NULL
rel	NULL
,	NULL
Int	NULL
.	NULL
)	NULL

p	NULL
in	NULL
J	NULL
Q	NULL
}	NULL
/	NULL
Ir	NULL
``	NULL
,	NULL
RH	NULL
“	NULL
Ut	NULL
+	NULL
10	NULL
R	NULL
%	NULL
40	NULL
50	NULL
6	NULL
(	NULL
ane	NULL
)	NULL
Figure	NULL
6	NULL
.	NULL

Hypersensitive	NULL
site	NULL
formation	NULL
at	NULL
the	NULL
mutant	NULL
fp	NULL
1-3	NULL
sequence	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
mEKLF	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Schematic	NULL
drawing	NULL
of	NULL
the	NULL
mutant	NULL
reporter	NULL
transgene	NULL
array	NULL
and	NULL
the	NULL
strategy	NULL
used	NULL
to	NULL
detect	NULL
hypersensitivity	NULL
at	NULL
fp	NULL
1-3	NULL
.	NULL

The	NULL
Hpal-A	NULL
cel	NULL
probe	NULL
does	NULL
not	NULL
detect	NULL
the	NULL
mEKLF-pEV	NULL
transgene	NULL
(	NULL
Needham	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
(	NULL
bar	NULL
with	NULL
asterisk	NULL
)	NULL
hybridizes	NULL
to	NULL
the	NULL
4.3-kb	NULL
Nco	NULL
!	NULL

repeat	NULL
fragment	NULL
of	NULL
the	NULL
mutant	NULL
reporter	NULL
gene	NULL
.	NULL

The	NULL
0.9-kb	NULL
Apal-Ncol	NULL
fragment	NULL
marks	NULL
the	NULL
position	NULL
of	NULL
the	NULL
hypersensitive	NULL
site	NULL
(	NULL
see	NULL
B	NULL
)	NULL
.	NULL

(	NULL
Other	NULL
details	NULL
are	NULL
as	NULL
for	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL
)	NULL

(	NULL
B	NULL
)	NULL
Southern	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
hypersensitive	NULL
site	NULL
at	NULL
the	NULL
mutant	NULL
fp	NULL
1-3	NULL
sequence	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
E13.5	NULL
fetal	NULL
livers	NULL
from	NULL
mutant	NULL
reporter	NULL
and	NULL
mutant	NULL
reporter/mEKLF-pEV	NULL
transgenics	NULL
as	NULL
indicated	NULL
.	NULL

Nuclei	NULL
were	NULL
digested	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
DNase	NULL
I	NULL
,	NULL
and	NULL
DNA	NULL
was	NULL
purified	NULL
,	NULL
cut	NULL
with	NULL
Nco	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
Southern	NULL
blotting	NULL
.	NULL

The	NULL
DNA	NULL
in	NULL
lane	NULL
8	NULL
was	NULL
digested	NULL
with	NULL
Nco	NULL
!	NULL

and	NULL
Apal	NULL
to	NULL
mark	NULL
the	NULL
position	NULL
of	NULL
fp	NULL
1-3	NULL
(	NULL
arrow	NULL
,	NULL
Apal-N	NULL
eol	NULL
)	NULL
.	NULL

The	NULL
repeat	NULL
band	NULL
of	NULL
the	NULL
mutant	NULL
reporter	NULL
transgene	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
(	NULL
NcoX	NULL
)	NULL
,	NULL
the	NULL
hypersensitive	NULL
site	NULL
at	NULL
mutant	NULL
fp	NULL
1-3	NULL
by	NULL
a	NULL
bracket	NULL
(	NULL
HS	NULL
)	NULL
.	NULL

(	NULL
Bottom	NULL
)	NULL
The	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
rehybridized	NULL
with	NULL
a	NULL
probe	NULL
detecting	NULL
an	NULL
0.85-kb	NULL
Ncol	NULL
fragment	NULL
of	NULL
the	NULL
mouse	NULL
a	NULL
,	NULL
-globin	NULL
gene	NULL
(	NULL
m-	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Quantitation	NULL
of	NULL
the	NULL
hypersensitive	NULL
site	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
.	NULL

The	NULL
signal	NULL
in	NULL
the	NULL
hypersensitive	NULL
site	NULL
was	NULL
divided	NULL
by	NULL
the	NULL
signal	NULL
in	NULL
the	NULL
corresponding	NULL
mouse	NULL
a	NULL
,	NULL
-globin	NULL
band	NULL
[	NULL
(	NULL
y-axis	NULL
)	NULL
relative	NULL
intensity	NULL
of	NULL
the	NULL
hypersensitive	NULL
site	NULL
]	NULL
and	NULL
plotted	NULL
against	NULL
the	NULL
lane	NULL
number	NULL
(	NULL
x-axis	NULL
)	NULL
.	NULL

(	NULL
@	NULL
)	NULL
Mutant	NULL
reporter	NULL
;	NULL
(	NULL
@	NULL
)	NULL
mutant	NULL
reporter	NULL
plus	NULL
m	NULL
EKLF-pEV	NULL
.	NULL

data	NULL
that	NULL
direct	NULL
binding	NULL
of	NULL
EKLF	NULL
is	NULL
implicated	NULL
in	NULL
the	NULL
chromatin	NULL
remodeling	NULL
activity	NULL
of	NULL
5'HS3	NULL
of	NULL
the	NULL
-globin	NULL
LCR	NULL
(	NULL
Ellis	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

EKLF	NULL
but	NULL
not	NULL
Sp1	NULL
is	NULL
an	NULL
activator	NULL
of	NULL
the	NULL
LCR	NULL
Discussion	NULL
Binary	NULL
transgenic	NULL
systems	NULL
In	NULL
this	NULL
paper	NULL
we	NULL
have	NULL
used	NULL
binary	NULL
transgenic	NULL
mice	NULL
to	NULL
investigate	NULL
the	NULL
apparent	NULL
redundancy	NULL
of	NULL
transcription	NULL
factors	NULL
binding	NULL
to	NULL
an	NULL
important	NULL
genetic	NULL
element	NULL
,	NULL
5'HS3	NULL
of	NULL
the	NULL
B-globin	NULL
LCR	NULL
.	NULL

Our	NULL
approach	NULL
encompasses	NULL
the	NULL
use	NULL
of	NULL
engineered	NULL
zinc	NULL
finger	NULL
transcription	NULL
factors	NULL
rationally	NULL
designed	NULL
to	NULL
recognize	NULL
a	NULL
mutated	NULL
binding	NULL
site	NULL
in	NULL
5'HS3	NULL
.	NULL

Several	NULL
binary	NULL
systems	NULL
for	NULL
regulating	NULL
gene	NULL
expression	NULL
have	NULL
been	NULL
described	NULL
,	NULL
for	NULL
instance	NULL
,	NULL
the	NULL
yeast	NULL
GAL4/UAS	NULL
,	NULL
the	NULL
bacterial	NULL
tet-repressor/operator	NULL
,	NULL
and	NULL
steroid-inducible	NULL
systems	NULL
(	NULL
Ornitz	NULL
et	NULL
al	NULL
.	NULL

1991	NULL
;	NULL
Gossen	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
;	NULL
No	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
;	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
an	NULL
engineered	NULL
zinc	NULL
finger	NULL
domain	NULL
recognizing	NULL
a	NULL
unique	NULL
region	NULL
of	NULL
the	NULL
BCR-ABL	NULL
fusion	NULL
oncogene	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
impair	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
oncogene	NULL
in	NULL
transformed	NULL
cells	NULL
after	NULL
transient	NULL
transfection	NULL
in	NULL
culture	NULL
(	NULL
Choo	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
show	NULL
that	NULL
engineered	NULL
zinc	NULL
finger	NULL
transcription	NULL
factors	NULL
are	NULL
particularly	NULL
useful	NULL
tools	NULL
for	NULL
the	NULL
study	NULL
of	NULL
tissue-specific	NULL
activation	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Transcription	NULL
factors	NULL
with	NULL
altered	NULL
binding	NULL
specificities	NULL
Previously	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
DNA-binding	NULL
specificity	NULL
of	NULL
the	NULL
Drosophila	NULL
fushi	NULL
tarazu	NULL
(	NULL
fiz	NULL
)	NULL
protein	NULL
can	NULL
be	NULL
altered	NULL
by	NULL
changing	NULL
a	NULL
single	NULL
amino	NULL
acid	NULL
in	NULL
its	NULL
homeodomain	NULL
.	NULL

This	NULL
was	NULL
used	NULL
to	NULL
demonstrate	NULL
direct	NULL
autoregulation	NULL
through	NULL
binding	NULL
of	NULL
the	NULL
fiz	NULL
mutant	NULL
to	NULL
mutant	NULL
DNA	NULL
target	NULL
sites	NULL
in	NULL
a	NULL
regulatory	NULL
element	NULL
of	NULL
the	NULL
fz	NULL
gene	NULL
,	NULL
establishing	NULL
that	NULL
this	NULL
in	NULL
vivo	NULL
approach	NULL
can	NULL
be	NULL
used	NULL
to	NULL
distinguish	NULL
between	NULL
activities	NULL
of	NULL
homeodomain	NULL
proteins	NULL
with	NULL
very	NULL
similar	NULL
binding	NULL
site	NULL
specificities	NULL
(	NULL
Schier	NULL
and	NULL
Gehring	NULL
1992	NULL
)	NULL
.	NULL

Most	NULL
transcription	NULL
factors	NULL
are	NULL
mem	NULL
bers	NULL
of	NULL
families	NULL
classified	NULL
by	NULL
highly	NULL
conserved	NULL
DNA-binding	NULL
domains	NULL
.	NULL

Members	NULL
of	NULL
such	NULL
families	NULL
recognize	NULL
very	NULL
similar	NULL
or	NULL
even	NULL
identical	NULL
DNA	NULL
sequences	NULL
and	NULL
are	NULL
often	NULL
found	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
types	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
family	NULL
members	NULL
may	NULL
have	NULL
overlapping	NULL
arrays	NULL
of	NULL
target	NULL
genes	NULL
,	NULL
and	NULL
in	NULL
many	NULL
cases	NULL
it	NULL
has	NULL
proved	NULL
impossible	NULL
to	NULL
show	NULL
which	NULL
factor	NULL
activates	NULL
which	NULL
gene	NULL
.	NULL

5'HS3	NULL
of	NULL
the	NULL
B-globin	NULL
LCR	NULL
is	NULL
a	NULL
good	NULL
example	NULL
of	NULL
this	NULL
problem	NULL
.	NULL

The	NULL
core	NULL
fragment	NULL
contains	NULL
three	NULL
GATA	NULL
footprints	NULL
interspersed	NULL
by	NULL
three	NULL
footprints	NULL
over	NULL
G	NULL
boxes	NULL
;	NULL
fp	NULL
1-3	NULL
of	NULL
the	NULL
core	NULL
are	NULL
minimally	NULL
required	NULL
for	NULL
activity	NULL
in	NULL
transgenic	NULL
mice	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Because	NULL
GATA-1	NULL
is	NULL
the	NULL
only	NULL
GATA	NULL
family	NULL
member	NULL
present	NULL
at	NULL
late	NULL
stages	NULL
of	NULL
erythroid	NULL
differentiation	NULL
,	NULL
point	NULL
mutagenesis	NULL
and	NULL
in	NULL
vivo	NULL
footprinting	NULL
analyses	NULL
have	NULL
demonstrated	NULL
convincingly	NULL
that	NULL
GATA-1	NULL
interacts	NULL
with	NULL
the	NULL
GATA	NULL
sites	NULL
of	NULL
fp	NULL
1	NULL
and	NULL
3	NULL
in	NULL
vivo	NULL
(	NULL
Strauss	NULL
and	NULL
Orkin	NULL
1992	NULL
;	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
G	NULL
boxes	NULL
of	NULL
fp	NULL
2	NULL
are	NULL
bound	NULL
in	NULL
vitro	NULL
by	NULL
a	NULL
num	NULL
ber	NULL
of	NULL
different	NULL
proteins	NULL
belonging	NULL
to	NULL
the	NULL
Sp1	NULL
family	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

These	NULL
proteins	NULL
have	NULL
very	NULL
similar	NULL
binding	NULL
sites	NULL
,	NULL
and	NULL
no	NULL
mutations	NULL
specific	NULL
for	NULL
individual	NULL
factors	NULL
could	NULL
be	NULL
made	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

To	NULL
resolve	NULL
this	NULL
issue	NULL
,	NULL
we	NULL
have	NULL
introduced	NULL
compensatory	NULL
mutations	NULL
in	NULL
the	NULL
zinc	NULL
finger	NULL
domains	NULL
of	NULL
the	NULL
Spl	NULL
family	NULL
members	NULL
Spl	NULL
and	NULL
EKLF	NULL
designed	NULL
to	NULL
interact	NULL
with	NULL
a	NULL
mutated	NULL
G	NULL
box	NULL
in	NULL
fp	NULL
2	NULL
.	NULL

Our	NULL
data	NULL
show	NULL
that	NULL
m	NULL
EKLF	NULL
activates	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
2869	NULL
Gillemans	NULL
et	NULL
al	NULL
.	NULL

the	NULL
mutated	NULL
5'HS3	NULL
fragment	NULL
in	NULL
binary	NULL
transgenic	NULL
mice	NULL
by	NULL
binding	NULL
directly	NULL
to	NULL
the	NULL
fp	NULL
2	NULL
mutant	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
m	NULL
Spl	NULL
does	NULL
not	NULL
act	NULL
as	NULL
an	NULL
activator	NULL
in	NULL
this	NULL
context	NULL
,	NULL
even	NULL
though	NULL
it	NULL
interacts	NULL
specifically	NULL
with	NULL
the	NULL
fp	NULL
2	NULL
mutant	NULL
in	NULL
vitro	NULL
and	NULL
is	NULL
a	NULL
functional	NULL
transactivator	NULL
through	NULL
this	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
OVEC	NULL
vector	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
specific	NULL
properties	NULL
of	NULL
EKLF	NULL
are	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
5'HS3	NULL
.	NULL

Our	NULL
data	NULL
do	NULL
not	NULL
rule	NULL
out	NULL
that	NULL
other	NULL
factors	NULL
are	NULL
also	NULL
capable	NULL
of	NULL
activating	NULL
5'HS3	NULL
.	NULL

Possible	NULL
candidates	NULL
are	NULL
other	NULL
Spl	NULL
family	NULL
members	NULL
such	NULL
as	NULL
BKLF	NULL
and	NULL
Sp3	NULL
(	NULL
Hagen	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
;	NULL
Crossley	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
,	NULL
or	NULL
the	NULL
recently	NULL
described	NULL
multitype	NULL
zinc	NULL
finger	NULL
protein	NULL
Friend	NULL
of	NULL
GAT	NULL
(	NULL
Tsang	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

It	NULL
remains	NULL
possible	NULL
that	NULL
such	NULL
proteins	NULL
function	NULL
as	NULL
activators	NULL
of	NULL
5'HS3	NULL
through	NULL
direct	NULL
interaction	NULL
with	NULL
the	NULL
wild-type	NULL
fp	NULL
2	NULL
sequence	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
reporter	NULL
genes	NULL
are	NULL
present	NULL
as	NULL
multicopy	NULL
concatemers	NULL
,	NULL
and	NULL
thus	NULL
synergism	NULL
among	NULL
the	NULL
multiple	NULL
insertions	NULL
might	NULL
occur	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
test	NULL
the	NULL
activity	NULL
of	NULL
mutant	NULL
binding	NULL
sites/mu-tant	NULL
transcription	NULL
factor	NULL
combinations	NULL
in	NULL
the	NULL
structural	NULL
context	NULL
of	NULL
single	NULL
copy	NULL
integrants	NULL
of	NULL
the	NULL
complete	NULL
human	NULL
B-globin	NULL
locus	NULL
(	NULL
Strouboulis	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
)	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
replacement	NULL
of	NULL
fp	NULL
2	NULL
with	NULL
a	NULL
completely	NULL
artificial	NULL
binding	NULL
site	NULL
will	NULL
have	NULL
a	NULL
stronger	NULL
effect	NULL
on	NULL
the	NULL
remaining	NULL
activity	NULL
of	NULL
fp	NULL
1-3	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

The	NULL
construction	NULL
of	NULL
novel	NULL
zinc	NULL
finger	NULL
domains	NULL
recognizing	NULL
the	NULL
artificial	NULL
site	NULL
would	NULL
be	NULL
required	NULL
to	NULL
activate	NULL
such	NULL
a	NULL
mutant	NULL
reporter	NULL
gene	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
specificity	NULL
of	NULL
zinc	NULL
finger	NULL
domains	NULL
can	NULL
be	NULL
changed	NULL
efficiently	NULL
by	NULL
successive	NULL
rounds	NULL
of	NULL
affinity	NULL
selection	NULL
through	NULL
randomization	NULL
of	NULL
the	NULL
recognition	NULL
helix	NULL
of	NULL
each	NULL
finger	NULL
(	NULL
Greisman	NULL
and	NULL
Pabo	NULL
1997	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
second	NULL
generation	NULL
of	NULL
mutant	NULL
Spl	NULL
family	NULL
members	NULL
could	NULL
be	NULL
designed	NULL
that	NULL
interacts	NULL
with	NULL
a	NULL
completely	NULL
arbitrary	NULL
sequence	NULL
in	NULL
fp	NULL
2	NULL
,	NULL
resulting	NULL
in	NULL
more	NULL
stringent	NULL
activator/reporter	NULL
combinations	NULL
.	NULL

EKLF	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
-globin	NULL
locus	NULL
In	NULL
this	NULL
paper	NULL
we	NULL
have	NULL
used	NULL
binary	NULL
transgenic	NULL
mice	NULL
to	NULL
show	NULL
that	NULL
EKLF	NULL
is	NULL
an	NULL
activator	NULL
of	NULL
the	NULL
LCR	NULL
that	NULL
binds	NULL
directly	NULL
to	NULL
fp	NULL
2	NULL
of	NULL
5	NULL
!	NULL

HS3	NULL
.	NULL

EKLF	NULL
appears	NULL
to	NULL
function	NULL
in	NULL
a	NULL
specific	NULL
combination	NULL
with	NULL
GATA-1	NULL
bound	NULL
at	NULL
fp	NULL
1	NULL
and	NULL
3	NULL
,	NULL
consistent	NULL
with	NULL
earlier	NULL
results	NULL
obtained	NULL
with	NULL
point	NULL
mutations	NULL
and	NULL
deletions	NULL
in	NULL
5'HS3	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
Pru-zina	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
an	NULL
in	NULL
vivo	NULL
binding	NULL
site	NULL
for	NULL
EKLF	NULL
in	NULL
the	NULL
B-globin	NULL
LCR	NULL
.	NULL

Targeted	NULL
inactivation	NULL
of	NULL
the	NULL
EKLF	NULL
gene	NULL
in	NULL
mice	NULL
results	NULL
in	NULL
lethality	NULL
around	NULL
E14-15	NULL
caused	NULL
by	NULL
severe	NULL
anemia	NULL
due	NULL
to	NULL
failure	NULL
to	NULL
express	NULL
the	NULL
B-globin	NULL
gene	NULL
at	NULL
appropriate	NULL
levels	NULL
(	NULL
Nuez	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
;	NULL
Perkins	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
other	NULL
erythroid-specific	NULL
genes	NULL
examined	NULL
,	NULL
including	NULL
the	NULL
«	NULL
-like	NULL
and	NULL
the	NULL
embryonic/fetal	NULL
B-like	NULL
globins	NULL
,	NULL
is	NULL
not	NULL
affected	NULL
showing	NULL
that	NULL
EKLF	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
adult	NULL
B-globin	NULL
promoter	NULL
(	NULL
Nuez	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
;	NULL
Perkins	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
;	NULL
Wijgerde	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
recently	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
5'HS3-lacZ	NULL
transgenes	NULL
requires	NULL
EKLF	NULL
(	NULL
Tewari	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
)	NULL
,	NULL
and	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
site	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
locus	NULL
in	NULL
the	NULL
EKLF	NULL
null	NULL
background	NULL
showed	NULL
2870	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
strongly	NULL
reduced	NULL
sensitivity	NULL
at	NULL
the	NULL
B-globin	NULL
promoter	NULL
and	NULL
moderately	NULL
reduced	NULL
sensitivity	NULL
at	NULL
5'HS3	NULL
(	NULL
Wijgerde	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

These	NULL
data	NULL
agree	NULL
well	NULL
with	NULL
our	NULL
observation	NULL
that	NULL
direct	NULL
binding	NULL
of	NULL
mEKLF	NULL
to	NULL
the	NULL
mutant	NULL
fp	NULL
1-3	NULL
sequence	NULL
results	NULL
in	NULL
elevated	NULL
reporter	NULL
gene	NULL
expression	NULL
and	NULL
increased	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
at	NULL
fp	NULL
1-3	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
direct	NULL
binding	NULL
of	NULL
EKLF	NULL
is	NULL
implicated	NULL
in	NULL
chromatin	NULL
remodeling	NULL
over	NULL
5'HS3	NULL
,	NULL
the	NULL
only	NULL
LCR	NULL
fragment	NULL
that	NULL
appears	NULL
to	NULL
have	NULL
an	NULL
intrinsic	NULL
dominant	NULL
chromatin	NULL
opening	NULL
activity	NULL
(	NULL
Ellis	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
5'HS3	NULL
in	NULL
the	NULL
human	NULL
or	NULL
the	NULL
mouse	NULL
locus	NULL
does	NULL
not	NULL
inactivate	NULL
the	NULL
LCR	NULL
completely	NULL
(	NULL
Hug	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
;	NULL
Milot	NULL
et	NULL
al	NULL
.	NULL

1996b	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
5'HS3	NULL
in	NULL
the	NULL
endogenous	NULL
mouse	NULL
locus	NULL
results	NULL
in	NULL
a	NULL
30	NULL
%	NULL
reduction	NULL
of	NULL
B	NULL
gene	NULL
expression	NULL
in	NULL
adult	NULL
mice	NULL
(	NULL
Hug	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

Natural	NULL
mutations	NULL
in	NULL
the	NULL
CACC	NULL
box	NULL
of	NULL
the	NULL
B-globin	NULL
promoter	NULL
result	NULL
in	NULL
a	NULL
less	NULL
severe	NULL
reduction	NULL
of	NULL
B	NULL
gene	NULL
expression	NULL
than	NULL
observed	NULL
in	NULL
EKLF	NULL
knockout	NULL
mice	NULL
(	NULL
Thein	NULL
1993	NULL
;	NULL
Perkins	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
;	NULL
Wijgerde	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
EKLF	NULL
sites	NULL
are	NULL
necessary	NULL
in	NULL
both	NULL
the	NULL
promoter	NULL
and	NULL
the	NULL
LCR	NULL
and	NULL
that	NULL
these	NULL
sites	NULL
act	NULL
independently	NULL
of	NULL
each	NULL
other	NULL
.	NULL

Remarkably	NULL
,	NULL
these	NULL
interactions	NULL
occur	NULL
in	NULL
a	NULL
different	NULL
context	NULL
of	NULL
other	NULL
factors	NULL
,	NULL
and	NULL
it	NULL
is	NULL
of	NULL
interest	NULL
to	NULL
note	NULL
that	NULL
EKLF	NULL
is	NULL
not	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
y-globin	NULL
promoter	NULL
in	NULL
fetal	NULL
liver	NULL
cells	NULL
,	NULL
whereas	NULL
it	NULL
is	NULL
essential	NULL
for	NULL
B-globin	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
(	NULL
Perkins	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
;	NULL
Wijgerde	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
direct	NULL
binding	NULL
of	NULL
EKLF	NULL
to	NULL
both	NULL
the	NULL
LCR	NULL
and	NULL
the	NULL
B	NULL
promoter	NULL
is	NULL
mandatory	NULL
for	NULL
high	NULL
level	NULL
transcription	NULL
of	NULL
the	NULL
adult	NULL
B-globin	NULL
gene	NULL
.	NULL

Outlook	NULL
Direct	NULL
binding	NULL
of	NULL
EKLF	NULL
appears	NULL
to	NULL
be	NULL
pivotal	NULL
for	NULL
the	NULL
function	NULL
of	NULL
5	NULL
!	NULL

HS3	NULL
and	NULL
the	NULL
B-globin	NULL
promoter	NULL
.	NULL

Therefore	NULL
,	NULL
mutation	NULL
of	NULL
both	NULL
elements	NULL
should	NULL
result	NULL
in	NULL
a	NULL
reporter	NULL
gene	NULL
that	NULL
is	NULL
expressed	NULL
at	NULL
extremely	NULL
low	NULL
levels	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
appropriate	NULL
m	NULL
EKLF	NULL
.	NULL

Rendering	NULL
m	NULL
EKLF	NULL
steroid	NULL
dependent	NULL
by	NULL
fusing	NULL
it	NULL
to	NULL
a	NULL
steroid-receptor	NULL
ligand	NULL
binding	NULL
domain	NULL
would	NULL
give	NULL
an	NULL
additional	NULL
level	NULL
of	NULL
control	NULL
to	NULL
study	NULL
the	NULL
kinetics	NULL
of	NULL
gene	NULL
activation	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

The	NULL
feasibility	NULL
of	NULL
steroid-inducible	NULL
target	NULL
gene	NULL
expression	NULL
in	NULL
binary	NULL
transgenic	NULL
mice	NULL
has	NULL
been	NULL
demonstrated	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

Inducible	NULL
activation	NULL
of	NULL
LCR-dependent	NULL
gene	NULL
expression	NULL
provides	NULL
an	NULL
in	NULL
vivo	NULL
system	NULL
that	NULL
can	NULL
be	NULL
used	NULL
to	NULL
address	NULL
different	NULL
aspects	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
for	NULL
instance	NULL
,	NULL
recruitment	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
to	NULL
the	NULL
promoter	NULL
,	NULL
interactions	NULL
between	NULL
the	NULL
LCR	NULL
and	NULL
the	NULL
promoter	NULL
through	NULL
DN	NULL
A	NULL
looping	NULL
,	NULL
and	NULL
the	NULL
potential	NULL
link	NULL
between	NULL
transcriptional	NULL
activation	NULL
and	NULL
DNA	NULL
replication	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Milot	NULL
et	NULL
al	NULL
.	NULL

1996a	NULL
;	NULL
Ptashne	NULL
and	NULL
Gann	NULL
1997	NULL
)	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
exploring	NULL
these	NULL
issues	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
complete	NULL
human	NULL
B-globin	NULL
locus	NULL
(	NULL
Strouboulis	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
)	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
DNA	NULL
constructs	NULL
and	NULL
transgenesis	NULL
Mutations	NULL
were	NULL
introduced	NULL
in	NULL
the	NULL
fp	NULL
1-3	NULL
region	NULL
of	NULL
5'HS3	NULL
as	NULL
described	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
,	NULL
and	NULL
linked	NULL
to	NULL
the	NULL
Hpal-EcoRV	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
gene	NULL
.	NULL

The	NULL
microinjection	NULL
fragments	NULL
were	NULL
released	NULL
from	NULL
vector	NULL
sequences	NULL
by	NULL
digestion	NULL
with	NULL
EcoRV	NULL
,	NULL
gel	NULL
purified	NULL
and	NULL
used	NULL
for	NULL
transgenesis	NULL
(	NULL
Kollias	NULL
et	NULL
al	NULL
.	NULL

1986	NULL
)	NULL
.	NULL

Founder	NULL
transgenics	NULL
were	NULL
either	NULL
dissected	NULL
at	NULL
E13.5	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
,	NULL
1993	NULL
;	NULL
Talbot	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
or	NULL
bred	NULL
to	NULL
obtain	NULL
lines	NULL
.	NULL

Intactness	NULL
,	NULL
mosaicism	NULL
,	NULL
and	NULL
copy	NULL
numbers	NULL
of	NULL
the	NULL
transgenes	NULL
were	NULL
analyzed	NULL
by	NULL
Southern	NULL
blotting	NULL
(	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

To	NULL
change	NULL
the	NULL
binding	NULL
specificity	NULL
of	NULL
fingers	NULL
1	NULL
and	NULL
3	NULL
of	NULL
EKLF	NULL
and	NULL
Spl	NULL
,	NULL
the	NULL
amino	NULL
acid	NULL
substitutions	NULL
indicated	NULL
in	NULL
Figure	NULL
2A	NULL
were	NULL
introduced	NULL
by	NULL
PCR-mediated	NULL
mutagenesis	NULL
;	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
cloned	NULL
PCR	NULL
products	NULL
was	NULL
verified	NULL
by	NULL
dideoxy	NULL
sequencing	NULL
(	NULL
Sambrook	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
;	NULL
the	NULL
mutated	NULL
proteins	NULL
were	NULL
designated	NULL
mEKLF	NULL
and	NULL
mSp1	NULL
.	NULL

For	NULL
transfection	NULL
experiments	NULL
in	NULL
CHO	NULL
cells	NULL
,	NULL
cDNAs	NULL
encoding	NULL
Spl	NULL
,	NULL
mSp1	NULL
,	NULL
and	NULL
mEKLF	NULL
were	NULL
cloned	NULL
in	NULL
the	NULL
Not	NULL
!	NULL

site	NULL
of	NULL
the	NULL
expression	NULL
vector	NULL
pRe/CMV	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

Control	NULL
and	NULL
mutant	NULL
binding	NULL
sites	NULL
were	NULL
cloned	NULL
in	NULL
the	NULL
site	NULL
of	NULL
the	NULL
OVEC	NULL
vector	NULL
(	NULL
Westin	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

The	NULL
integrity	NULL
and	NULL
orientation	NULL
of	NULL
the	NULL
cloned	NULL
oligonucleotides	NULL
was	NULL
determined	NULL
by	NULL
dideoxy	NULL
se-quencing	NULL
.	NULL

For	NULL
erythroid-specific	NULL
expression	NULL
,	NULL
the	NULL
EKLF	NULL
,	NULL
m	NULL
EKLF	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
mSpl	NULL
cDNAs	NULL
were	NULL
cloned	NULL
in	NULL
the	NULL
vector	NULL
pEV3	NULL
(	NULL
Needham	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
EKLF-pEV	NULL
,	NULL
mEKLF-pEV	NULL
,	NULL
Sp1l-pEV	NULL
,	NULL
and	NULL
mSp1l-pEV	NULL
.	NULL

Microinjection	NULL
fragments	NULL
for	NULL
transgenesis	NULL
were	NULL
obtained	NULL
by	NULL
digestion	NULL
with	NULL
Aafll	NULL
and	NULL
Asp718	NULL
.	NULL

Cell	NULL
transfections	NULL
CHO	NULL
cells	NULL
(	NULL
0.5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
transfected	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
method	NULL
(	NULL
Graham	NULL
and	NULL
Van	NULL
der	NULL
Eb	NULL
1973	NULL
)	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
OVEC	NULL
test	NULL
vector	NULL
,	NULL
0.15	NULL
ug	NULL
of	NULL
OVEC-REF	NULL
vector	NULL
,	NULL
and	NULL
0.1	NULL
,	NULL
0.5	NULL
,	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
appropriate	NULL
pRe/CMV	NULL
expression	NULL
vector	NULL
,	NULL
supplemented	NULL
with	NULL
pTZ	NULL
to	NULL
a	NULL
total	NULL
amount	NULL
of	NULL
18	NULL
ug	NULL
of	NULL
DNA	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
72	NULL
hr	NULL
and	NULL
used	NULL
to	NULL
prepare	NULL
RN	NULL
A	NULL
(	NULL
Antoniou	NULL
1991	NULL
)	NULL
.	NULL

MEL	NULL
cells	NULL
(	NULL
25	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
25	NULL
ug	NULL
of	NULL
pEV3	NULL
derivatives	NULL
linearized	NULL
with	NULL
Scal	NULL
.	NULL

After	NULL
selection	NULL
for	NULL
G418	NULL
resistance	NULL
,	NULL
erythroid	NULL
differentiation	NULL
was	NULL
induced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
dimethylsulfoxide	NULL
(	NULL
2	NULL
%	NULL
vol/vol	NULL
)	NULL
to	NULL
the	NULL
media	NULL
(	NULL
Antoniou	NULL
1991	NULL
)	NULL
.	NULL

After	NULL
4	NULL
days	NULL
of	NULL
induction	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
protein	NULL
extracts	NULL
were	NULL
made	NULL
according	NULL
to	NULL
Scholer	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

Fetal	NULL
liver	NULL
protein	NULL
and	NULL
RNA	NULL
samples	NULL
Fetal	NULL
livers	NULL
were	NULL
dissected	NULL
from	NULL
E13.5	NULL
fetuses	NULL
and	NULL
frozen	NULL
immediately	NULL
in	NULL
liquid	NULL
nitrogen	NULL
.	NULL

RN	NULL
A	NULL
was	NULL
isolated	NULL
from	NULL
frozen	NULL
tissue	NULL
samples	NULL
as	NULL
described	NULL
(	NULL
Antoniou	NULL
1991	NULL
;	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Protein	NULL
was	NULL
extracted	NULL
according	NULL
to	NULL
Scholer	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

Western	NULL
blotting	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
,	NULL
using	NULL
20	NULL
ug	NULL
of	NULL
protein	NULL
per	NULL
lane	NULL
(	NULL
Marin	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
antibodies	NULL
recognizing	NULL
EKLF	NULL
and	NULL
Sp1	NULL
were	NULL
used	NULL
in	NULL
1:3000	NULL
and	NULL
1:1000	NULL
dilutions	NULL
,	NULL
respectively	NULL
.	NULL

As	NULL
a	NULL
loading	NULL
control	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
reprobed	NULL
with	NULL
a	NULL
rat	NULL
monoclonal	NULL
antibody	NULL
directed	NULL
against	NULL
GATA-1	NULL
(	NULL
N6	NULL
,	NULL
cat	NULL
.	NULL

no	NULL
.	NULL

sc-265	NULL
,	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
used	NULL
at	NULL
3	NULL
ng/ul	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
transgene	NULL
was	NULL
quantitated	NULL
by	NULL
S1	NULL
nuclease	NULL
analysis	NULL
,	NULL
using	NULL
a	NULL
probe	NULL
specific	NULL
for	NULL
human	NULL
B-globin	NULL
mRNA	NULL
,	NULL
and	NULL
probes	NULL
detecting	NULL
mouse	NULL
B-major	NULL
or	NULL
mouse	NULL
«	NULL
-globin	NULL
mRNA	NULL
as	NULL
the	NULL
internal	NULL
control	NULL
(	NULL
Antoniou	NULL
1991	NULL
;	NULL
Philipsen	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Gel	NULL
retardation	NULL
analysis	NULL
Oligonucleotide	NULL
probes	NULL
covering	NULL
fp	NULL
2	NULL
were	NULL
labeled	NULL
and	NULL
annealed	NULL
according	NULL
to	NULL
Wall	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
.	NULL

Double-stranded	NULL
competitor	NULL
oligonucleotides	NULL
were	NULL
added	NULL
at	NULL
the	NULL
amounts	NULL
indicated	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
extract	NULL
to	NULL
the	NULL
reactions	NULL
.	NULL

Polyclonal	NULL
antibodies	NULL
rec-	NULL
EKLF	NULL
but	NULL
not	NULL
Sp1	NULL
is	NULL
an	NULL
activator	NULL
of	NULL
the	NULL
LCR	NULL
ognizing	NULL
Sp1	NULL
,	NULL
Sp3	NULL
,	NULL
and	NULL
EKLF	NULL
were	NULL
used	NULL
at	NULL
1:160	NULL
,	NULL
1:320	NULL
,	NULL
and	NULL
1:40	NULL
dilutions	NULL
in	NULL
the	NULL
binding	NULL
reactions	NULL
,	NULL
respectively	NULL
.	NULL

Incubation	NULL
was	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
loaded	NULL
on	NULL
4	NULL
%	NULL
polyacrylamide	NULL
(	NULL
PAA	NULL
)	NULL
/	NULL
0.5	NULL
%	NULL
TBE	NULL
gels	NULL
and	NULL
run	NULL
at	NULL
300	NULL
V	NULL
for	NULL
3	NULL
hr	NULL
at	NULL
4°C	NULL
.	NULL

Other	NULL
details	NULL
are	NULL
described	NULL
in	NULL
Wall	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
are	NULL
as	NULL
follows	NULL
(	NULL
only	NULL
the	NULL
sense	NULL
strand	NULL
is	NULL
shown	NULL
)	NULL
fp	NULL
2	NULL
control	NULL
,	NULL
5-AGGTTCCAGT-GAGTTTGGGGTGGGGTCAGTG-3	NULL
'	NULL
;	NULL
fp	NULL
2	NULL
mutant	NULL
,	NULL
5'-AG-GTTCCAGTGAGTTTGTGGTGGTGTCAGTG-3	NULL
'	NULL
;	NULL
and	NULL
Spl	NULL
,	NULL
S'-ATAGTCCCGCCCCTAACTCCGCCCAT-3	NULL
'	NULL
.	NULL

Bases	NULL
different	NULL
from	NULL
the	NULL
wild-type	NULL
sequence	NULL
of	NULL
fp	NULL
2	NULL
are	NULL
underlined	NULL
;	NULL
bases	NULL
different	NULL
between	NULL
control	NULL
fp	NULL
2	NULL
and	NULL
mutant	NULL
fp	NULL
2	NULL
are	NULL
underlined	NULL
and	NULL
in	NULL
boldface	NULL
type	NULL
.	NULL

Prim	NULL
ary	NULL
transcript	NULL
in	NULL
situ	NULL
hybridization	NULL
E13.5	NULL
livers	NULL
from	NULL
individual	NULL
fetuses	NULL
were	NULL
disrupted	NULL
in	NULL
150	NULL
ul	NULL
of	NULL
PBS	NULL
.	NULL

Twenty	NULL
microliters	NULL
of	NULL
this	NULL
cell	NULL
suspension	NULL
was	NULL
spotted	NULL
onto	NULL
a	NULL
polylysine-coated	NULL
slide	NULL
and	NULL
fixed	NULL
in	NULL
4	NULL
%	NULL
formaldehyde	NULL
,	NULL
5	NULL
%	NULL
acetic	NULL
acid	NULL
,	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
then	NULL
washed	NULL
three	NULL
times	NULL
for	NULL
10	NULL
min	NULL
in	NULL
PBS	NULL
and	NULL
stored	NULL
in	NULL
70	NULL
%	NULL
ethanol	NULL
at	NULL
-20°C	NULL
.	NULL

Two	NULL
sets	NULL
of	NULL
probes	NULL
were	NULL
used	NULL
for	NULL
in	NULL
situ	NULL
hy-bridization	NULL
.	NULL

Four	NULL
biotinylated	NULL
oligonucleotides	NULL
were	NULL
used	NULL
to	NULL
detect	NULL
human	NULL
B-globin	NULL
transcription	NULL
.	NULL

This	NULL
probe	NULL
mixture	NULL
is	NULL
directed	NULL
against	NULL
intron	NULL
1	NULL
;	NULL
two	NULL
of	NULL
the	NULL
oligonucleotides	NULL
overlap	NULL
partially	NULL
with	NULL
exon	NULL
sequences	NULL
and	NULL
thus	NULL
cytoplasmic	NULL
B-globin	NULL
mRNA	NULL
can	NULL
also	NULL
be	NULL
detected	NULL
(	NULL
Dillon	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

Three	NULL
DIG-labeled	NULL
mouse	NULL
«	NULL
-globin	NULL
intron-specific	NULL
oligonucleotides	NULL
were	NULL
used	NULL
to	NULL
reveal	NULL
the	NULL
erythroid	NULL
cells	NULL
(	NULL
Tewari	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

Hybrid-izations	NULL
were	NULL
done	NULL
as	NULL
described	NULL
by	NULL
Tewari	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
and	NULL
Wijgerde	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

For	NULL
antibody	NULL
detection	NULL
,	NULL
the	NULL
Tyramid	NULL
amplification	NULL
system	NULL
of	NULL
Dupont	NULL
NEN	NULL
was	NULL
used	NULL
(	NULL
Raap	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
)	NULL
.	NULL

For	NULL
quantitation	NULL
,	NULL
at	NULL
least	NULL
300	NULL
cells	NULL
were	NULL
scored	NULL
for	NULL
each	NULL
slide	NULL
.	NULL

The	NULL
reproducibility	NULL
of	NULL
these	NULL
data	NULL
fell	NULL
within	NULL
a	NULL
10	NULL
%	NULL
error	NULL
margin	NULL
.	NULL

The	NULL
following	NULL
oligonucleotides	NULL
were	NULL
used	NULL
for	NULL
in	NULL
situ	NULL
hybrid-izations	NULL
:	NULL
Human	NULL
B-globin	NULL
,	NULL
5-CTGTCTCCACATGCCCAGTT-TCTATGGTCTCCTTAAACCTGTCTTGTAA-3	NULL
'	NULL
,	NULL
5	NULL
TGGGAAAATAGACCAAAGGCAGAGAGAGTCAGTGCC-TATCAGAAAC-3	NULL
'	NULL
,	NULL
5-AGGGCAGTAACGGCAGACTCTCC-TCAGGAGTCAGGT-3	NULL
'	NULL
,	NULL
and	NULL
5'-ATAACAGCATCAGGAGG-GACAGATCCCCAAAGGACTCA-3	NULL
'	NULL
;	NULL
Mouse	NULL
a-globin	NULL
,	NULL
5'-CA-CAGAAAAGCATAGTTAGAAGCGCCCACTGAGCGAGT-	NULL
5-AGCCCTTCCTAGGGGCCCAGATGC-CGCCTGCCAGGTCCC-3	NULL
'	NULL
,	NULL
and	NULL
5-GCTCCCCTTCCTGG-GACCACTATGTCCCTGCCTTGGGCACGAGGACCC-3	NULL
'	NULL
.	NULL

DNase	NULL
I	NULL
hypersensitivity	NULL
assay	NULL
Ten	NULL
E13.5	NULL
livers	NULL
were	NULL
used	NULL
to	NULL
isolate	NULL
nuclei	NULL
followed	NULL
by	NULL
treatment	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
DNase	NULL
I	NULL
at	NULL
37°C	NULL
(	NULL
Ellis	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
DNA	NULL
was	NULL
purified	NULL
,	NULL
digested	NULL
with	NULL
NcoI	NULL
,	NULL
and	NULL
Southern	NULL
blotted	NULL
.	NULL

A	NULL
0.44-kb	NULL
Hpal-Acel	NULL
fragment	NULL
from	NULL
the	NULL
B-globin	NULL
promoter	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
to	NULL
detect	NULL
the	NULL
hypersensitive	NULL
site	NULL
at	NULL
fp	NULL
1-3	NULL
.	NULL

A	NULL
0.6-kb	NULL
BamHI-Sacl	NULL
fragment	NULL
of	NULL
the	NULL
mouse	NULL
a	NULL
,	NULL
globin	NULL
gene	NULL
,	NULL
detecting	NULL
a	NULL
0.85-kb	NULL
Nco	NULL
!	NULL

fragment	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
probe	NULL
.	NULL

Quantitation	NULL
was	NULL
done	NULL
on	NULL
a	NULL
PhosphorImager	NULL
with	NULL
Im	NULL
ag-ecQuant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Drs	NULL
.	NULL

Jim	NULL
Kadonaga	NULL
,	NULL
Jim	NULL
Bicker	NULL
,	NULL
and	NULL
Guntram	NULL
Suske	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
Spl	NULL
cDNA	NULL
and	NULL
EKLF	NULL
and	NULL
Sp1/Sp3	NULL
antibodies	NULL
,	NULL
respectively	NULL
.	NULL

We	NULL
are	NULL
indebted	NULL
to	NULL
Dr.	NULL
Albert	NULL
Brinkman	NULL
and	NULL
Cor	NULL
Berrevoets	NULL
for	NULL
help	NULL
with	NULL
the	NULL
transfection	NULL
assays	NULL
.	NULL

R.T.	NULL
,	NULL
FL	NULL
.	NULL

and	NULL
M.W	NULL
.	NULL

were	NULL
supported	NULL
by	NULL
a	NULL
Netherlands	NULL
Organisatie	NULL
voor	NULL
Weten-	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
2871	NULL
Gillemans	NULL
et	NULL
al	NULL
.	NULL

schappelijk	NULL
Orderzoek	NULL
(	NULL
The	NULL
Netherlands	NULL
)	NULL
grant	NULL
to	NULL
F.G.	NULL
T.dW	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
Therexsys	NULL
(	NULL
UK	NULL
)	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
'advertisement	NULL
'	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
USC	NULL
section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
References	NULL
Anderson	NULL
,	NULL
K.P	NULL
.	NULL

,	NULL
C.B	NULL
.	NULL

Kern	NULL
,	NULL
S.C.	NULL
Crable	NULL
,	NULL
and	NULL
J.B.	NULL
Lingrel	NULL
.	NULL

1995	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
functional	NULL
zinc	NULL
finger	NULL
protein	NULL
homologous	NULL
to	NULL
erythroid	NULL
Kruppel-like	NULL
factor	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
new	NULL
multigene	NULL
family	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

151	NULL
5957-5965	NULL
.	NULL

Antoniou	NULL
,	NULL
M.	NULL
1991	NULL
.	NULL

Induction	NULL
of	NULL
erythroid-specific	NULL
expression	NULL
in	NULL
murine	NULL
erythroleukemia	NULL
(	NULL
MEL	NULL
)	NULL
cell	NULL
lines	NULL
.	NULL

Methods	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
:	NULL
421-434	NULL
.	NULL

Choo	NULL
,	NULL
Y.	NULL
and	NULL
A.	NULL
Klug	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
role	NULL
in	NULL
DNA	NULL
binding	NULL
for	NULL
the	NULL
linker	NULL
sequences	NULL
of	NULL
the	NULL
first	NULL
three	NULL
zinc	NULL
fingers	NULL
of	NULL
TFIIA	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

211	NULL
3341-3346	NULL
.	NULL

Choo	NULL
,	NULL
Y.	NULL
,	NULL
I.	NULL
Sanchez-Garcia	NULL
,	NULL
and	NULL
A.	NULL
Klug	NULL
.	NULL

1994	NULL
.	NULL

In	NULL
vivo	NULL
repression	NULL
by	NULL
a	NULL
site-specific	NULL
DNA-binding	NULL
protein	NULL
designed	NULL
against	NULL
an	NULL
oncogenic	NULL
sequence	NULL
.	NULL

Nature	NULL
372	NULL
:	NULL
642-645	NULL
.	NULL

Crossley	NULL
,	NULL
M.	NULL
,	NULL
E.	NULL
Whitelaw	NULL
,	NULL
A.	NULL
Perkins	NULL
,	NULL
G.	NULL
Williams	NULL
,	NULL
Y.	NULL
Fujiwara	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1996	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
cDNA	NULL
encoding	NULL
BKLF/TEF-2	NULL
,	NULL
a	NULL
major	NULL
CACCC-box-binding	NULL
protein	NULL
in	NULL
erythroid	NULL
cells	NULL
and	NULL
selected	NULL
other	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

161	NULL
1695-1705	NULL
.	NULL

Desjarlais	NULL
,	NULL
J.R.	NULL
and	NULL
J.M	NULL
.	NULL

Berg	NULL
.	NULL

1993	NULL
.	NULL

Use	NULL
of	NULL
a	NULL
zinc-finger	NULL
consensus	NULL
sequence	NULL
framework	NULL
and	NULL
specificity	NULL
rules	NULL
to	NULL
design	NULL
specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

90	NULL
:	NULL
2256-2260	NULL
.	NULL

Dillon	NULL
,	NULL
N.	NULL
,	NULL
T.	NULL
Trim	NULL
born	NULL
,	NULL
J.	NULL
Strouboulis	NULL
,	NULL
P.	NULL
Fraser	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
distance	NULL
on	NULL
long-range	NULL
chromatin	NULL
interactions	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
11131-139	NULL
.	NULL

Ellis	NULL
,	NULL
J.	NULL
,	NULL
K.C	NULL
.	NULL

Tanun	NULL
,	NULL
A.	NULL
Harper	NULL
,	NULL
D.	NULL
Michalovich	NULL
,	NULL
N.	NULL
Yannoutsos	NULL
,	NULL
S.	NULL
Philipsen	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
dominant	NULL
chromatin-opening	NULL
activity	NULL
in	NULL
5	NULL
'	NULL
hypersensitive	NULL
site	NULL
3	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
locus	NULL
control	NULL
region	NULL
.	NULL

EMBO	NULL
J	NULL
15	NULL
:	NULL
562-568	NULL
.	NULL

Feng	NULL
,	NULL
W.C.	NULL
,	NULL
C.M	NULL
.	NULL

Southwood	NULL
,	NULL
and	NULL
J.J.	NULL
Bieker	NULL
.	NULL

1994	NULL
.	NULL

Analyses	NULL
of	NULL
B-thalassemia	NULL
mutant	NULL
DNA	NULL
interactions	NULL
with	NULL
erythroid	NULL
Kruppel-like	NULL
factor	NULL
(	NULL
EKLF	NULL
)	NULL
,	NULL
an	NULL
erythroid	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
.	NULL

Z	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
:	NULL
1493-1500	NULL
.	NULL

Fraser	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
Hurst	NULL
,	NULL
P.	NULL
Collis	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1990	NULL
.	NULL

DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
1	NULL
,	NULL
2	NULL
and	NULL
3	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
dominant	NULL
control	NULL
region	NULL
direct	NULL
position-independent	NULL
expression	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

181	NULL
3503-3508	NULL
.	NULL

Gossen	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Freundlieb	NULL
,	NULL
G.	NULL
Bender	NULL
,	NULL
G.	NULL
Muller	NULL
,	NULL
W.	NULL
Hillen	NULL
,	NULL
and	NULL
H.	NULL
Bujard	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
activation	NULL
by	NULL
tetracyclines	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Science	NULL
268	NULL
:	NULL
1766-1769	NULL
.	NULL

Graham	NULL
,	NULL
FL	NULL
.	NULL

and	NULL
A.J	NULL
van	NULL
der	NULL
Eb	NULL
.	NULL

1973	NULL
.	NULL

A	NULL
new	NULL
technique	NULL
for	NULL
the	NULL
assay	NULL
of	NULL
infectivity	NULL
of	NULL
human	NULL
adenovirus	NULL
5	NULL
DNA	NULL
.	NULL

Virology	NULL
52:456-467	NULL
.	NULL

Greisman	NULL
,	NULL
H.A	NULL
.	NULL

and	NULL
C.O	NULL
.	NULL

Pabo	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
general	NULL
strategy	NULL
for	NULL
selecting	NULL
high-affinity	NULL
zinc	NULL
finger	NULL
proteins	NULL
for	NULL
diverse	NULL
DNA	NULL
target	NULL
sites	NULL
.	NULL

Science	NULL
2751657-661	NULL
.	NULL

Grosveld	NULL
,	NULL
F.	NULL
,	NULL
N.	NULL
Dillon	NULL
,	NULL
and	NULL
D.	NULL
Higgs	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
human	NULL
globin	NULL
gene	NULL
expression	NULL
.	NULL

Bailliere	NULL
's	NULL
Clin	NULL
.	NULL

Hematol	NULL
.	NULL

6	NULL
:	NULL
31-55	NULL
.	NULL

Hagen	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Muller	NULL
,	NULL
M.	NULL
Beato	NULL
,	NULL
and	NULL
G.	NULL
Suske	NULL
.	NULL

1992	NULL
.	NULL

Cloning	NULL
by	NULL
recognition	NULL
site	NULL
screening	NULL
of	NULL
two	NULL
novel	NULL
GT	NULL
box	NULL
binding	NULL
proteins	NULL
:	NULL
a	NULL
family	NULL
of	NULL
Spl	NULL
related	NULL
genes	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
:	NULL
5519-5525.	NULL
.	NULL

1994	NULL
.	NULL

Spl-mediated	NULL
transcriptional	NULL
activation	NULL
is	NULL
repressed	NULL
by	NULL
Sp3	NULL
.	NULL

EMBO	NULL
J	NULL
13:3843-3851	NULL
.	NULL

Hug	NULL
,	NULL
B.A	NULL
.	NULL

,	NULL
RL	NULL
.	NULL

Wesselschmidt	NULL
,	NULL
S.	NULL
Fiering	NULL
,	NULL
M.A	NULL
.	NULL

Bender	NULL
,	NULL
E.	NULL
Epner	NULL
,	NULL
M.	NULL
Groudine	NULL
,	NULL
and	NULL
T.J.	NULL
Ley	NULL
.	NULL

1996	NULL
.	NULL

Analysis	NULL
of	NULL
mice	NULL
2872	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
containing	NULL
a	NULL
targeted	NULL
deletion	NULL
of	NULL
B-globin	NULL
locus	NULL
control	NULL
region	NULL
5	NULL
'	NULL
hypersensitive	NULL
site	NULL
3	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
:	NULL
2906-2912	NULL
.	NULL

Imataka	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Sogawa	NULL
,	NULL
K.	NULL
Yasumoto	NULL
,	NULL
Y.	NULL
Kikuchi	NULL
,	NULL
K.	NULL
Sasano	NULL
,	NULL
A.	NULL
Kobayashi	NULL
,	NULL
M.	NULL
Hayami	NULL
,	NULL
and	NULL
Y.	NULL
Fujii-Kuriyama	NULL
.	NULL

1992	NULL
.	NULL

Two	NULL
regulatory	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
basic	NULL
transcription	NULL
element	NULL
(	NULL
BTE	NULL
)	NULL
,	NULL
a	NULL
GC	NULL
box	NULL
sequence	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
rat	NULL
P4501A1	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:3663-3671	NULL
.	NULL

Isalan	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Choo	NULL
,	NULL
and	NULL
A.	NULL
Klug	NULL
.	NULL

1997	NULL
.	NULL

Synergy	NULL
between	NULL
adjacent	NULL
zinc	NULL
fingers	NULL
in	NULL
sequence-specific	NULL
DNA	NULL
recognition	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

941	NULL
5617-5621	NULL
.	NULL

Jacobs	NULL
,	NULL
G.H	NULL
.	NULL

1992	NULL
.	NULL

Determination	NULL
of	NULL
the	NULL
base	NULL
recognition	NULL
positions	NULL
of	NULL
zinc	NULL
fingers	NULL
from	NULL
sequence	NULL
analysis	NULL
.	NULL

EMBO	NULL
J	NULL
11	NULL
:	NULL
4507-4517	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.T	NULL
.	NULL

,	NULL
K.R	NULL
.	NULL

Carner	NULL
,	NULL
FR	NULL
.	NULL

Masiarz	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

Isolation	NULL
of	NULL
cDNA	NULL
encoding	NULL
transcription	NULL
factor	NULL
Spl	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Cell	NULL
51	NULL
:	NULL
1079-1090	NULL
.	NULL

Kingsley	NULL
,	NULL
C.	NULL
and	NULL
A.	NULL
Winoto	NULL
.	NULL

1992	NULL
.	NULL

Cloning	NULL
of	NULL
GT	NULL
box-binding	NULL
proteins	NULL
:	NULL
A	NULL
novel	NULL
Spl	NULL
multigene	NULL
family	NULL
regulating	NULL
T-cell	NULL
receptor	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

1214251-4261	NULL
.	NULL

Kollias	NULL
,	NULL
G.	NULL
,	NULL
N.	NULL
Wrighton	NULL
,	NULL
J.	NULL
Hurst	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1986	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
human	NULL
A	NULL
y-	NULL
,	NULL
B-	NULL
,	NULL
and	NULL
hybrid	NULL
y	NULL
B-globin	NULL
genes	NULL
in	NULL
transgenic	NULL
mice	NULL
:	NULL
manipulation	NULL
of	NULL
the	NULL
developmental	NULL
expression	NULL
patterns	NULL
.	NULL

Cell	NULL
46	NULL
:	NULL
89-94	NULL
.	NULL

Letovsky	NULL
,	NULL
J.	NULL
and	NULL
W.S	NULL
.	NULL

Dynan	NULL
.	NULL

1989	NULL
.	NULL

Measurement	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
transcription	NULL
factor	NULL
Spl	NULL
to	NULL
a	NULL
single	NULL
GC	NULL
box	NULL
recognition	NULL
sequence	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
:	NULL
2639-2653	NULL
.	NULL

Li	NULL
,	NULL
R.	NULL
,	NULL
J.D	NULL
.	NULL

Knight	NULL
,	NULL
S.P	NULL
.	NULL

Jackson	NULL
,	NULL
R.	NULL
Tjian	NULL
,	NULL
and	NULL
M.R	NULL
.	NULL

Botchan	NULL
.	NULL

1991	NULL
.	NULL

Direct	NULL
interaction	NULL
between	NULL
Spl	NULL
and	NULL
the	NULL
BPV	NULL
enhancer	NULL
E2	NULL
protein	NULL
mediates	NULL
synergistic	NULL
activation	NULL
of	NULL
transcription	NULL
.	NULL

Cell	NULL
651493-505	NULL
.	NULL

Marin	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Karis	NULL
,	NULL
P.	NULL
Visser	NULL
,	NULL
F.	NULL
Grosveld	NULL
,	NULL
and	NULL
S.	NULL
Philipsen	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
factor	NULL
Spl	NULL
is	NULL
essential	NULL
for	NULL
early	NULL
embryonic	NULL
development	NULL
but	NULL
dispensable	NULL
for	NULL
cell	NULL
growth	NULL
and	NULL
differ-entiation	NULL
.	NULL

Cell	NULL
89	NULL
:	NULL
619-628	NULL
.	NULL

Merika	NULL
,	NULL
M.	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1995	NULL
.	NULL

Functional	NULL
synergy	NULL
and	NULL
physical	NULL
interactions	NULL
of	NULL
the	NULL
erythroid	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
with	NULL
the	NULL
Kruppel	NULL
family	NULL
proteins	NULL
Spl	NULL
and	NULL
EKLF	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

151	NULL
2437-2447	NULL
.	NULL

Miller	NULL
,	NULL
LJ	NULL
.	NULL

and	NULL
J.J.	NULL
Bicker	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
novel	NULL
,	NULL
erythroid	NULL
cell-specific	NULL
murine	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
CACCC	NULL
element	NULL
and	NULL
is	NULL
related	NULL
to	NULL
the	NULL
Kruppel	NULL
family	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
:	NULL
2776-2786	NULL
.	NULL

Milot	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Fraser	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1996a	NULL
.	NULL

Position	NULL
effects	NULL
and	NULL
genetic	NULL
disease	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

12	NULL
:	NULL
123-126	NULL
.	NULL

Milot	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
Strouboulis	NULL
,	NULL
T.	NULL
Trimborn	NULL
,	NULL
M.	NULL
Wijgerde	NULL
,	NULL
E.	NULL
Deboer	NULL
,	NULL
A.	NULL
Langeveld	NULL
,	NULL
K.	NULL
Tanun	NULL
,	NULL
W.	NULL
Vergeer	NULL
,	NULL
N.	NULL
Yannoutsos	NULL
,	NULL
F.	NULL
Grosveld	NULL
,	NULL
and	NULL
P.	NULL
Fraser	NULL
.	NULL

1996b	NULL
.	NULL

Heterochromatin	NULL
effects	NULL
on	NULL
the	NULL
frequency	NULL
and	NULL
duration	NULL
of	NULL
LCR-mediated	NULL
gene	NULL
transcription	NULL
.	NULL

Cell	NULL
87:105-114	NULL
.	NULL

Narayan	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
R.W	NULL
.	NULL

Kriwacki	NULL
,	NULL
and	NULL
JP	NULL
.	NULL

Caradonna	NULL
.	NULL

1997	NULL
.	NULL

Structures	NULL
of	NULL
zinc	NULL
finger	NULL
domains	NULL
from	NULL
transcription	NULL
factor	NULL
Spl	NULL
.	NULL

Insights	NULL
into	NULL
sequence-specific	NULL
protein-DNA	NULL
recognition	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2721	NULL
7801-7809	NULL
.	NULL

Needham	NULL
,	NULL
M.	NULL
,	NULL
C.	NULL
Gooding	NULL
,	NULL
K.	NULL
Hudson	NULL
,	NULL
M.	NULL
Antoniou	NULL
,	NULL
F.	NULL
Grosveld	NULL
,	NULL
and	NULL
M.	NULL
Hollis	NULL
.	NULL

1992	NULL
.	NULL

LCR/MEL	NULL
:	NULL
A	NULL
versatile	NULL
system	NULL
for	NULL
high-level	NULL
expression	NULL
of	NULL
heterologous	NULL
proteins	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:997-1003	NULL
.	NULL

No	NULL
,	NULL
D.	NULL
,	NULL
TP	NULL
.	NULL

Yao	NULL
,	NULL
and	NULL
R.M	NULL
.	NULL

Evans	NULL
.	NULL

1996	NULL
.	NULL

Ecdysone-inducible	NULL
gene	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
and	NULL
transgenic	NULL
mice	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

931	NULL
3346-3351	NULL
.	NULL

Nuez	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
Michalovich	NULL
,	NULL
A.	NULL
Bygrave	NULL
,	NULL
R.	NULL
Ploemacher	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1995	NULL
.	NULL

Defective	NULL
haematopoiesis	NULL
in	NULL
fetal	NULL
liver	NULL
resulting	NULL
from	NULL
inactivation	NULL
of	NULL
the	NULL
EKLF	NULL
gene	NULL
.	NULL

Nature	NULL
375	NULL
:	NULL
316-318	NULL
.	NULL

Ornitz	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
RW	NULL
.	NULL

Moreadith	NULL
,	NULL
and	NULL
P.	NULL
Leder	NULL
.	NULL

1991	NULL
.	NULL

Binary	NULL
sys-	NULL
tem	NULL
for	NULL
regulating	NULL
transgene	NULL
expression	NULL
in	NULL
mice	NULL
:	NULL
Targeting	NULL
int-2	NULL
gene	NULL
expression	NULL
with	NULL
yeast	NULL
GAL4/UAS	NULL
control	NULL
ele-ments	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

881	NULL
:	NULL
698-702	NULL
.	NULL

Pavletich	NULL
,	NULL
N.P	NULL
.	NULL

and	NULL
C.O0	NULL
.	NULL

Pabo	NULL
.	NULL

1991	NULL
.	NULL

Zinc	NULL
finger-DN	NULL
A	NULL
recogni-tion	NULL
:	NULL
crystal	NULL
structure	NULL
of	NULL
a	NULL
Zif268-DNA	NULL
complex	NULL
at	NULL
2.1	NULL
A	NULL
.	NULL

Science	NULL
2521	NULL
809-817	NULL
.	NULL

Perkins	NULL
,	NULL
N.D.	NULL
,	NULL
A.B	NULL
.	NULL

Agranoff	NULL
,	NULL
E.	NULL
Pascal	NULL
,	NULL
and	NULL
G.J	NULL
.	NULL

Nabel	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
interaction	NULL
between	NULL
the	NULL
DNA-binding	NULL
domains	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
Spl	NULL
mediates	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
gene	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
:	NULL
6570-6583	NULL
.	NULL

Perkins	NULL
,	NULL
A.C.	NULL
,	NULL
A.H.	NULL
Sharpe	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1995	NULL
.	NULL

Lethal	NULL
B-thalassaemia	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
erythroid	NULL
CACCC-tran-scription	NULL
factor	NULL
EKLEF	NULL
.	NULL

Nature	NULL
375:318-322	NULL
.	NULL

Perkins	NULL
,	NULL
A.C.	NULL
,	NULL
KM	NULL
.	NULL

Gaensler	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1996	NULL
.	NULL

Silencing	NULL
of	NULL
human	NULL
fetal	NULL
globin	NULL
expression	NULL
is	NULL
impaired	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
adult	NULL
B-globin	NULL
gene	NULL
activator	NULL
protein	NULL
EKLF	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

931	NULL
:	NULL
12267-12271	NULL
.	NULL

Philipsen	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Talbot	NULL
,	NULL
P.	NULL
Fraser	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
B-globin	NULL
dominant	NULL
control	NULL
region	NULL
:	NULL
Hypersensitive	NULL
site	NULL
2	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9	NULL
:	NULL
2159-2167	NULL
.	NULL

Philipsen	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Pruzina	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
minimal	NULL
requirements	NULL
for	NULL
activity	NULL
in	NULL
transgenic	NULL
mice	NULL
of	NULL
hypersensitive	NULL
site	NULL
3	NULL
of	NULL
the	NULL
B	NULL
globin	NULL
locus	NULL
control	NULL
region	NULL
.	NULL

EMBO	NULL
J	NULL
12	NULL
:	NULL
1077-1085	NULL
.	NULL

Pruzina	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Antoniou	NULL
,	NULL
J.	NULL
Hurst	NULL
,	NULL
F.	NULL
Grosveld	NULL
,	NULL
and	NULL
S.	NULL
Philipsen	NULL
.	NULL

1994	NULL
.	NULL

Transcriptional	NULL
activation	NULL
by	NULL
hypersensitive	NULL
site	NULL
three	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
locus	NULL
control	NULL
region	NULL
in	NULL
murine	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
12191	NULL
351-360	NULL
.	NULL

Ptashne	NULL
,	NULL
M.	NULL
and	NULL
A.	NULL
Gann	NULL
.	NULL

1997	NULL
.	NULL

Transcriptional	NULL
activation	NULL
by	NULL
recruitment	NULL
.	NULL

Nature	NULL
386	NULL
:	NULL
569-577	NULL
.	NULL

Raap	NULL
,	NULL
A.K	NULL
.	NULL

,	NULL
M.P	NULL
.	NULL

van	NULL
de	NULL
Corput	NULL
,	NULL
R.A.	NULL
Vervenne	NULL
,	NULL
R.P	NULL
.	NULL

van	NULL
Gijl-swijk	NULL
,	NULL
H.J	NULL
.	NULL

Tanke	NULL
,	NULL
and	NULL
J.	NULL
Wiegant	NULL
.	NULL

1995	NULL
.	NULL

Ultra-sensitive	NULL
FISH	NULL
using	NULL
peroxidase-mediated	NULL
deposition	NULL
of	NULL
biotin-	NULL
or	NULL
fluoro-chrome	NULL
tyramides	NULL
.	NULL

Hum	NULL
.	NULL

Mol	NULL
.	NULL

Genet	NULL
.	NULL

4	NULL
:	NULL
529-534	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
EF	NULL
.	NULL

Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
A	NULL
laboratory	NULL
manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
.	NULL

Schier	NULL
,	NULL
A.F	NULL
.	NULL

and	NULL
W.J	NULL
.	NULL

Gehring	NULL
.	NULL

1992	NULL
.	NULL

Direct	NULL
homeodomain-DN	NULL
A	NULL
interaction	NULL
in	NULL
the	NULL
autoregulation	NULL
of	NULL
the	NULL
fushi	NULL
tarazu	NULL
gene	NULL
.	NULL

Nature	NULL
3561	NULL
804-807	NULL
.	NULL

Scholer	NULL
,	NULL
H.R	NULL
.	NULL

,	NULL
R.	NULL
Balling	NULL
,	NULL
A.K	NULL
.	NULL

Hatzopoulos	NULL
,	NULL
N.	NULL
Suzuki	NULL
,	NULL
and	NULL
P.	NULL
Gruss	NULL
.	NULL

1989	NULL
.	NULL

Octamer	NULL
binding	NULL
proteins	NULL
confer	NULL
transcriptional	NULL
activity	NULL
in	NULL
early	NULL
mouse	NULL
embryogenesis	NULL
.	NULL

EMBO	NULL
J	NULL
8	NULL
:	NULL
2551-2557	NULL
.	NULL

Shields	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
R.J.	NULL
Christy	NULL
,	NULL
and	NULL
V.W	NULL
.	NULL

Yang	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
gut-enriched	NULL
Kruppel-like	NULL
factor	NULL
expressed	NULL
during	NULL
growth	NULL
arrest	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
:	NULL
20009-20017	NULL
.	NULL

Sjottem	NULL
,	NULL
E.	NULL
,	NULL
C.	NULL
Andersen	NULL
,	NULL
and	NULL
T.	NULL
Johansen	NULL
.	NULL

1997	NULL
.	NULL

Structural	NULL
and	NULL
functional	NULL
analyses	NULL
of	NULL
DNA	NULL
bending	NULL
induced	NULL
by	NULL
Spl	NULL
family	NULL
transcription	NULL
factors	NULL
.	NULL

J	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

267	NULL
:	NULL
490-504	NULL
.	NULL

Strauss	NULL
,	NULL
E.C	NULL
.	NULL

and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1992	NULL
.	NULL

In	NULL
vivo	NULL
protein-DNA	NULL
interactions	NULL
at	NULL
hypersensitive	NULL
site	NULL
3	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
locus	NULL
control	NULL
region	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

891	NULL
5809-5813	NULL
.	NULL

Strouboulis	NULL
,	NULL
J.	NULL
,	NULL
N.	NULL
Dillon	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1992	NULL
.	NULL

Developmental	NULL
regulation	NULL
of	NULL
a	NULL
complete	NULL
70-kb	NULL
human	NULL
B-globin	NULL
locus	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

6	NULL
:	NULL
1857-1864	NULL
.	NULL

Talbot	NULL
,	NULL
D.	NULL
,	NULL
P.	NULL
Collis	NULL
,	NULL
M.	NULL
Antoniou	NULL
,	NULL
M.	NULL
Vidal	NULL
,	NULL
F.	NULL
Grosveld	NULL
,	NULL
and	NULL
D.R	NULL
.	NULL

Greaves	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
dominant	NULL
control	NULL
region	NULL
from	NULL
the	NULL
human	NULL
B-globin	NULL
locus	NULL
conferring	NULL
integration	NULL
site-indepen-dent	NULL
gene	NULL
expression	NULL
.	NULL

Nature	NULL
338	NULL
:	NULL
352-355	NULL
.	NULL

Tewari	NULL
,	NULL
R.	NULL
,	NULL
N.	NULL
Gillemans	NULL
,	NULL
A.	NULL
Harper	NULL
,	NULL
M.	NULL
Wijgerde	NULL
,	NULL
G.	NULL
Zafarana	NULL
,	NULL
D.	NULL
Drabek	NULL
,	NULL
F.	NULL
Grosveld	NULL
,	NULL
and	NULL
S.	NULL
Philipsen	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
human	NULL
B-globin	NULL
locus	NULL
control	NULL
region	NULL
confers	NULL
an	NULL
early	NULL
embryonic	NULL
erythroid-specific	NULL
expression	NULL
pattern	NULL
to	NULL
a	NULL
basic	NULL
promoter	NULL
driving	NULL
the	NULL
bacterial	NULL
lacZ	NULL
gene	NULL
.	NULL

Development	NULL
1221	NULL
3991-3999	NULL
.	NULL

EKLF	NULL
but	NULL
not	NULL
Sp1	NULL
is	NULL
an	NULL
activator	NULL
of	NULL
the	NULL
LCR	NULL
Tewari	NULL
,	NULL
R.	NULL
,	NULL
N.	NULL
Gillemans	NULL
,	NULL
M.	NULL
Wijgerde	NULL
,	NULL
B.	NULL
Nuez	NULL
,	NULL
M.	NULL
von	NULL
Lindern	NULL
,	NULL
F.	NULL
Grosveld	NULL
,	NULL
and	NULL
S.	NULL
Philipsen	NULL
.	NULL

1998	NULL
.	NULL

Erythroid	NULL
Kriippel-like	NULL
factor	NULL
(	NULL
EKLF	NULL
)	NULL
is	NULL
active	NULL
in	NULL
primitive	NULL
and	NULL
definitive	NULL
erythroid	NULL
cells	NULL
and	NULL
is	NULL
required	NULL
for	NULL
the	NULL
function	NULL
of	NULL
5'HS3	NULL
of	NULL
the	NULL
B-globin	NULL
locus	NULL
control	NULL
region	NULL
.	NULL

EMBO	NULL
J	NULL
17	NULL
:	NULL
2334-2341	NULL
.	NULL

Thein	NULL
,	NULL
S.L	NULL
.	NULL

1993	NULL
.	NULL

B-thalassaemia	NULL
.	NULL

Bailliere	NULL
's	NULL
Clin	NULL
.	NULL

Hematol	NULL
.	NULL

6	NULL
:	NULL
151-175	NULL
.	NULL

Tsang	NULL
,	NULL
A.P	NULL
.	NULL

,	NULL
J.E	NULL
.	NULL

Visvader	NULL
,	NULL
C.A	NULL
.	NULL

Turner	NULL
,	NULL
Y.	NULL
Fujiwara	NULL
,	NULL
C.N	NULL
.	NULL

Yu	NULL
,	NULL
M.J.	NULL
Weiss	NULL
,	NULL
M.	NULL
Crossley	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1997	NULL
.	NULL

FOG	NULL
,	NULL
a	NULL
multitype	NULL
zinc	NULL
finger	NULL
protein	NULL
,	NULL
acts	NULL
as	NULL
a	NULL
cofactor	NULL
for	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
in	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
differentia-tion	NULL
.	NULL

Cell	NULL
90	NULL
:	NULL
109-119	NULL
.	NULL

Wall	NULL
,	NULL
L.	NULL
,	NULL
E.	NULL
deBoer	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
human	NULL
B-globin	NULL
gene	NULL
3	NULL
'	NULL
enhancer	NULL
contains	NULL
multiple	NULL
binding	NULL
sites	NULL
for	NULL
an	NULL
erythroid-specific	NULL
protein	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

2	NULL
:	NULL
1089-1100	NULL
.	NULL

Wang	NULL
,	NULL
Y.L	NULL
.	NULL

,	NULL
F.J.	NULL
Demayo	NULL
,	NULL
S.Y	NULL
.	NULL

Tsai	NULL
,	NULL
and	NULL
B.W	NULL
.	NULL

Omalley	NULL
.	NULL

1997	NULL
.	NULL

Ligand-inducible	NULL
and	NULL
liver-specific	NULL
target	NULL
gene	NULL
expression	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Nat	NULL
.	NULL

Biotechnol	NULL
.	NULL

151	NULL
239-243	NULL
.	NULL

Westin	NULL
,	NULL
G.	NULL
,	NULL
T.	NULL
Gerster	NULL
,	NULL
M.M	NULL
.	NULL

Mueller	NULL
,	NULL
G.	NULL
Schaffner	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1987	NULL
.	NULL

OVEC	NULL
,	NULL
a	NULL
versatile	NULL
system	NULL
to	NULL
study	NULL
transcription	NULL
in	NULL
mammalian	NULL
cells	NULL
and	NULL
cell-free	NULL
extracts	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

151	NULL
6787-6798	NULL
.	NULL

Wijgerde	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
Grosveld	NULL
,	NULL
and	NULL
P.	NULL
Fraser	NULL
.	NULL

1995	NULL
.	NULL

Transcription	NULL
complex	NULL
stability	NULL
and	NULL
chromatin	NULL
dynamics	NULL
in	NULL
vivo	NULL
.	NULL

Nature	NULL
377:209-213	NULL
.	NULL

Wijgerde	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Gribnau	NULL
,	NULL
T.	NULL
Trim	NULL
born	NULL
,	NULL
B.	NULL
Nuez	NULL
,	NULL
S.	NULL
Philipsen	NULL
,	NULL
F.	NULL
Grosveld	NULL
,	NULL
and	NULL
P.	NULL
Fraser	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
role	NULL
of	NULL
EKLF	NULL
in	NULL
human	NULL
B-globin	NULL
gene	NULL
competition	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

10	NULL
:	NULL
2894-2902	NULL
.	NULL

GENES	NULL
&	NULL
DEVELOPMENT	NULL
2873	NULL

